#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


Text=Decreased brain connectivity in smoking contrasts with increased connectivity in drinking In a group of 831 participants from the general population in the Human Connectome Project, smokers exhibited low overall functional connectivity, and more specifically of the lateral orbitofrontal cortex which is associated with non-reward mechanisms, the adjacent inferior frontal gyrus, and the precuneus.
1-1	0-9	Decreased	_
1-2	10-15	brain	_
1-3	16-28	connectivity	_
1-4	29-31	in	_
1-5	32-39	smoking	_
1-6	40-49	contrasts	_
1-7	50-54	with	_
1-8	55-64	increased	_
1-9	65-77	connectivity	_
1-10	78-80	in	_
1-11	81-89	drinking	_
1-12	90-92	In	_
1-13	93-94	a	_
1-14	95-100	group	_
1-15	101-103	of	_
1-16	104-107	831	_
1-17	108-120	participants	_
1-18	121-125	from	_
1-19	126-129	the	_
1-20	130-137	general	_
1-21	138-148	population	_
1-22	149-151	in	_
1-23	152-155	the	_
1-24	156-161	Human	_
1-25	162-172	Connectome	_
1-26	173-180	Project	_
1-27	181-182	,	_
1-28	183-190	smokers	http://maven.renci.org/NeuroBridge/neurobridge#Person
1-29	191-200	exhibited	_
1-30	201-204	low	_
1-31	205-212	overall	_
1-32	213-223	functional	_
1-33	224-236	connectivity	_
1-34	237-238	,	_
1-35	239-242	and	_
1-36	243-247	more	_
1-37	248-260	specifically	_
1-38	261-263	of	_
1-39	264-267	the	_
1-40	268-275	lateral	_
1-41	276-289	orbitofrontal	_
1-42	290-296	cortex	_
1-43	297-302	which	_
1-44	303-305	is	_
1-45	306-316	associated	_
1-46	317-321	with	_
1-47	322-332	non-reward	_
1-48	333-343	mechanisms	_
1-49	344-345	,	_
1-50	346-349	the	_
1-51	350-358	adjacent	_
1-52	359-367	inferior	_
1-53	368-375	frontal	_
1-54	376-381	gyrus	_
1-55	382-383	,	_
1-56	384-387	and	_
1-57	388-391	the	_
1-58	392-401	precuneus	_
1-59	402-403	.	_

Text=Participants who drank a high amount had overall increases in resting state functional connectivity, and specific increases in reward-related systems including the medial orbitofrontal cortex and the cingulate cortex.
2-1	404-416	Participants	_
2-2	417-420	who	_
2-3	421-426	drank	_
2-4	427-428	a	_
2-5	429-433	high	_
2-6	434-440	amount	_
2-7	441-444	had	_
2-8	445-452	overall	_
2-9	453-462	increases	_
2-10	463-465	in	_
2-11	466-473	resting	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
2-12	474-479	state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
2-13	480-490	functional	_
2-14	491-503	connectivity	_
2-15	504-505	,	_
2-16	506-509	and	_
2-17	510-518	specific	_
2-18	519-528	increases	_
2-19	529-531	in	_
2-20	532-546	reward-related	_
2-21	547-554	systems	_
2-22	555-564	including	_
2-23	565-568	the	_
2-24	569-575	medial	_
2-25	576-589	orbitofrontal	_
2-26	590-596	cortex	_
2-27	597-600	and	_
2-28	601-604	the	_
2-29	605-614	cingulate	_
2-30	615-621	cortex	_
2-31	622-623	.	_

Text=Increased impulsivity was found in smokers, associated with decreased functional connectivity of the non-reward-related lateral orbitofrontal cortex; and increased impulsivity was found in high amount drinkers, associated with increased functional connectivity of the reward-related medial orbitofrontal cortex.
3-1	624-633	Increased	_
3-2	634-645	impulsivity	_
3-3	646-649	was	_
3-4	650-655	found	_
3-5	656-658	in	_
3-6	659-666	smokers	http://maven.renci.org/NeuroBridge/neurobridge#Person
3-7	667-668	,	_
3-8	669-679	associated	_
3-9	680-684	with	_
3-10	685-694	decreased	_
3-11	695-705	functional	_
3-12	706-718	connectivity	_
3-13	719-721	of	_
3-14	722-725	the	_
3-15	726-744	non-reward-related	_
3-16	745-752	lateral	_
3-17	753-766	orbitofrontal	_
3-18	767-773	cortex	_
3-19	774-775	;	_
3-20	776-779	and	_
3-21	780-789	increased	_
3-22	790-801	impulsivity	_
3-23	802-805	was	_
3-24	806-811	found	_
3-25	812-814	in	_
3-26	815-819	high	http://maven.renci.org/NeuroBridge/neurobridge#HighRisk
3-27	820-826	amount	http://maven.renci.org/NeuroBridge/neurobridge#HighRisk
3-28	827-835	drinkers	http://maven.renci.org/NeuroBridge/neurobridge#HighRisk
3-29	836-837	,	_
3-30	838-848	associated	_
3-31	849-853	with	_
3-32	854-863	increased	_
3-33	864-874	functional	_
3-34	875-887	connectivity	_
3-35	888-890	of	_
3-36	891-894	the	_
3-37	895-909	reward-related	_
3-38	910-916	medial	_
3-39	917-930	orbitofrontal	_
3-40	931-937	cortex	_
3-41	938-939	.	_

Text=The main findings were cross-validated in an independent longitudinal dataset with 1176 participants, IMAGEN.
4-1	940-943	The	_
4-2	944-948	main	_
4-3	949-957	findings	_
4-4	958-962	were	_
4-5	963-978	cross-validated	_
4-6	979-981	in	_
4-7	982-984	an	_
4-8	985-996	independent	_
4-9	997-1009	longitudinal	_
4-10	1010-1017	dataset	_
4-11	1018-1022	with	_
4-12	1023-1027	1176	_
4-13	1028-1040	participants	_
4-14	1041-1042	,	_
4-15	1043-1049	IMAGEN	_
4-16	1050-1051	.	_

Text=Further, the functional connectivities in 14-year-old non-smokers (and also in female low-drinkers) were related to who would smoke or drink at age 19.
5-1	1052-1059	Further	_
5-2	1060-1061	,	_
5-3	1062-1065	the	_
5-4	1066-1076	functional	_
5-5	1077-1091	connectivities	_
5-6	1092-1094	in	_
5-7	1095-1106	14-year-old	_
5-8	1107-1118	non-smokers	http://maven.renci.org/NeuroBridge/neurobridge#ReproductiveDisease
5-9	1119-1120	(	_
5-10	1121-1124	and	_
5-11	1125-1129	also	_
5-12	1130-1132	in	_
5-13	1133-1139	female	_
5-14	1140-1152	low-drinkers	_
5-15	1153-1154	)	_
5-16	1155-1159	were	_
5-17	1160-1167	related	_
5-18	1168-1170	to	_
5-19	1171-1174	who	_
5-20	1175-1180	would	_
5-21	1181-1186	smoke	_
5-22	1187-1189	or	_
5-23	1190-1195	drink	_
5-24	1196-1198	at	_
5-25	1199-1202	age	_
5-26	1203-1205	19	_
5-27	1206-1207	.	_

Text=An implication is that these differences in brain functional connectivities play a role in smoking and drinking, together with other factors.
6-1	1208-1210	An	_
6-2	1211-1222	implication	_
6-3	1223-1225	is	_
6-4	1226-1230	that	_
6-5	1231-1236	these	_
6-6	1237-1248	differences	_
6-7	1249-1251	in	_
6-8	1252-1257	brain	_
6-9	1258-1268	functional	_
6-10	1269-1283	connectivities	_
6-11	1284-1288	play	_
6-12	1289-1290	a	_
6-13	1291-1295	role	_
6-14	1296-1298	in	_
6-15	1299-1306	smoking	_
6-16	1307-1310	and	_
6-17	1311-1319	drinking	_
6-18	1320-1321	,	_
6-19	1322-1330	together	_
6-20	1331-1335	with	_
6-21	1336-1341	other	_
6-22	1342-1349	factors	_
6-23	1350-1351	.	_

Text=eLife digest To understand why people become addicted to alcohol or smoking, it is important to look at how the brains of people who use these substances may be different than those who abstain.
7-1	1352-1357	eLife	_
7-2	1358-1364	digest	_
7-3	1365-1367	To	_
7-4	1368-1378	understand	_
7-5	1379-1382	why	_
7-6	1383-1389	people	_
7-7	1390-1396	become	_
7-8	1397-1405	addicted	_
7-9	1406-1408	to	_
7-10	1409-1416	alcohol	_
7-11	1417-1419	or	_
7-12	1420-1427	smoking	_
7-13	1428-1429	,	_
7-14	1430-1432	it	_
7-15	1433-1435	is	_
7-16	1436-1445	important	_
7-17	1446-1448	to	_
7-18	1449-1453	look	_
7-19	1454-1456	at	_
7-20	1457-1460	how	_
7-21	1461-1464	the	_
7-22	1465-1471	brains	_
7-23	1472-1474	of	_
7-24	1475-1481	people	_
7-25	1482-1485	who	_
7-26	1486-1489	use	_
7-27	1490-1495	these	_
7-28	1496-1506	substances	_
7-29	1507-1510	may	_
7-30	1511-1513	be	_
7-31	1514-1523	different	_
7-32	1524-1528	than	_
7-33	1529-1534	those	_
7-34	1535-1538	who	_
7-35	1539-1546	abstain	_
7-36	1547-1548	.	_

Text=Many studies show that substance use activates the reward systems in the brain via a chemical called dopamine.
8-1	1549-1553	Many	_
8-2	1554-1561	studies	_
8-3	1562-1566	show	_
8-4	1567-1571	that	_
8-5	1572-1581	substance	_
8-6	1582-1585	use	_
8-7	1586-1595	activates	_
8-8	1596-1599	the	_
8-9	1600-1606	reward	_
8-10	1607-1614	systems	_
8-11	1615-1617	in	_
8-12	1618-1621	the	_
8-13	1622-1627	brain	_
8-14	1628-1631	via	_
8-15	1632-1633	a	_
8-16	1634-1642	chemical	_
8-17	1643-1649	called	_
8-18	1650-1658	dopamine	_
8-19	1659-1660	.	_

Text=Changes or differences in parts of the brain that control decision-making and restraint also have been implicated in substance use.
9-1	1661-1668	Changes	_
9-2	1669-1671	or	_
9-3	1672-1683	differences	_
9-4	1684-1686	in	_
9-5	1687-1692	parts	_
9-6	1693-1695	of	_
9-7	1696-1699	the	_
9-8	1700-1705	brain	_
9-9	1706-1710	that	_
9-10	1711-1718	control	_
9-11	1719-1734	decision-making	_
9-12	1735-1738	and	_
9-13	1739-1748	restraint	_
9-14	1749-1753	also	_
9-15	1754-1758	have	_
9-16	1759-1763	been	_
9-17	1764-1774	implicated	_
9-18	1775-1777	in	_
9-19	1778-1787	substance	_
9-20	1788-1791	use	_
9-21	1792-1793	.	_

Text=Functional magnetic resonance imaging (fMRI) is one tool scientists can use to explore such differences.
10-1	1794-1804	Functional	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
10-2	1805-1813	magnetic	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
10-3	1814-1823	resonance	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
10-4	1824-1831	imaging	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
10-5	1832-1833	(	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
10-6	1834-1838	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
10-7	1839-1840	)	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
10-8	1841-1843	is	_
10-9	1844-1847	one	_
10-10	1848-1852	tool	_
10-11	1853-1863	scientists	_
10-12	1864-1867	can	_
10-13	1868-1871	use	_
10-14	1872-1874	to	_
10-15	1875-1882	explore	_
10-16	1883-1887	such	_
10-17	1888-1899	differences	_
10-18	1900-1901	.	_

Text=It can measure how well different parts of the brain are communicating with each other by measuring their activity when a person is at rest.
11-1	1902-1904	It	_
11-2	1905-1908	can	_
11-3	1909-1916	measure	_
11-4	1917-1920	how	_
11-5	1921-1925	well	_
11-6	1926-1935	different	_
11-7	1936-1941	parts	_
11-8	1942-1944	of	_
11-9	1945-1948	the	_
11-10	1949-1954	brain	_
11-11	1955-1958	are	_
11-12	1959-1972	communicating	_
11-13	1973-1977	with	_
11-14	1978-1982	each	_
11-15	1983-1988	other	_
11-16	1989-1991	by	_
11-17	1992-2001	measuring	_
11-18	2002-2007	their	_
11-19	2008-2016	activity	_
11-20	2017-2021	when	_
11-21	2022-2023	a	_
11-22	2024-2030	person	_
11-23	2031-2033	is	_
11-24	2034-2036	at	_
11-25	2037-2041	rest	_
11-26	2042-2043	.	_

Text=The patterns of activity reveal which parts of the brain are working closely together or have high functional connectivity and which parts are less well connected, or have low functional connectivity.
12-1	2044-2047	The	_
12-2	2048-2056	patterns	_
12-3	2057-2059	of	_
12-4	2060-2068	activity	_
12-5	2069-2075	reveal	_
12-6	2076-2081	which	_
12-7	2082-2087	parts	_
12-8	2088-2090	of	_
12-9	2091-2094	the	_
12-10	2095-2100	brain	_
12-11	2101-2104	are	_
12-12	2105-2112	working	_
12-13	2113-2120	closely	_
12-14	2121-2129	together	_
12-15	2130-2132	or	_
12-16	2133-2137	have	_
12-17	2138-2142	high	_
12-18	2143-2153	functional	_
12-19	2154-2166	connectivity	_
12-20	2167-2170	and	_
12-21	2171-2176	which	_
12-22	2177-2182	parts	_
12-23	2183-2186	are	_
12-24	2187-2191	less	_
12-25	2192-2196	well	_
12-26	2197-2206	connected	_
12-27	2207-2208	,	_
12-28	2209-2211	or	_
12-29	2212-2216	have	_
12-30	2217-2220	low	_
12-31	2221-2231	functional	_
12-32	2232-2244	connectivity	_
12-33	2245-2246	.	_

Text=Cheng, Rolls et al.
13-1	2247-2252	Cheng	_
13-2	2253-2254	,	_
13-3	2255-2260	Rolls	_
13-4	2261-2263	et	_
13-5	2264-2266	al	_
13-6	2267-2268	.	_

Text=measured the functional connectivity between different parts of the brain in people who smoke and people who drink alcohol.
14-1	2269-2277	measured	_
14-2	2278-2281	the	_
14-3	2282-2292	functional	_
14-4	2293-2305	connectivity	_
14-5	2306-2313	between	_
14-6	2314-2323	different	_
14-7	2324-2329	parts	_
14-8	2330-2332	of	_
14-9	2333-2336	the	_
14-10	2337-2342	brain	_
14-11	2343-2345	in	_
14-12	2346-2352	people	_
14-13	2353-2356	who	_
14-14	2357-2362	smoke	_
14-15	2363-2366	and	_
14-16	2367-2373	people	_
14-17	2374-2377	who	_
14-18	2378-2383	drink	_
14-19	2384-2391	alcohol	_
14-20	2392-2393	.	_

Text=Smokers had a low overall functional connectivity between brain regions.
15-1	2394-2401	Smokers	http://maven.renci.org/NeuroBridge/neurobridge#Person
15-2	2402-2405	had	_
15-3	2406-2407	a	_
15-4	2408-2411	low	_
15-5	2412-2419	overall	_
15-6	2420-2430	functional	_
15-7	2431-2443	connectivity	_
15-8	2444-2451	between	_
15-9	2452-2457	brain	_
15-10	2458-2465	regions	_
15-11	2466-2467	.	_

Text=Specifically, they had weaker connections involving two brain regions that help people change or stop a behavior, the lateral orbitofrontal cortex and inferior frontal gyrus.
16-1	2468-2480	Specifically	_
16-2	2481-2482	,	_
16-3	2483-2487	they	_
16-4	2488-2491	had	_
16-5	2492-2498	weaker	_
16-6	2499-2510	connections	_
16-7	2511-2520	involving	_
16-8	2521-2524	two	_
16-9	2525-2530	brain	_
16-10	2531-2538	regions	_
16-11	2539-2543	that	_
16-12	2544-2548	help	_
16-13	2549-2555	people	_
16-14	2556-2562	change	_
16-15	2563-2565	or	_
16-16	2566-2570	stop	_
16-17	2571-2572	a	_
16-18	2573-2581	behavior	_
16-19	2582-2583	,	_
16-20	2584-2587	the	_
16-21	2588-2595	lateral	_
16-22	2596-2609	orbitofrontal	_
16-23	2610-2616	cortex	_
16-24	2617-2620	and	_
16-25	2621-2629	inferior	_
16-26	2630-2637	frontal	_
16-27	2638-2643	gyrus	_
16-28	2644-2645	.	_

Text=These differences may make people more impulsive and less able to resist smoking.
17-1	2646-2651	These	_
17-2	2652-2663	differences	_
17-3	2664-2667	may	_
17-4	2668-2672	make	_
17-5	2673-2679	people	_
17-6	2680-2684	more	_
17-7	2685-2694	impulsive	_
17-8	2695-2698	and	_
17-9	2699-2703	less	_
17-10	2704-2708	able	_
17-11	2709-2711	to	_
17-12	2712-2718	resist	_
17-13	2719-2726	smoking	_
17-14	2727-2728	.	_

Text=The stimulating effects of nicotine may enhance communication between different parts of the brain, so people also may use it to overcome some underlying communication deficits.
18-1	2729-2732	The	_
18-2	2733-2744	stimulating	_
18-3	2745-2752	effects	_
18-4	2753-2755	of	_
18-5	2756-2764	nicotine	_
18-6	2765-2768	may	_
18-7	2769-2776	enhance	_
18-8	2777-2790	communication	_
18-9	2791-2798	between	_
18-10	2799-2808	different	_
18-11	2809-2814	parts	_
18-12	2815-2817	of	_
18-13	2818-2821	the	_
18-14	2822-2827	brain	_
18-15	2828-2829	,	_
18-16	2830-2832	so	_
18-17	2833-2839	people	_
18-18	2840-2844	also	_
18-19	2845-2848	may	_
18-20	2849-2852	use	_
18-21	2853-2855	it	_
18-22	2856-2858	to	_
18-23	2859-2867	overcome	_
18-24	2868-2872	some	_
18-25	2873-2883	underlying	_
18-26	2884-2897	communication	_
18-27	2898-2906	deficits	_
18-28	2907-2908	.	_

Text=Those who drink alcohol had high overall functional connectivity.
19-1	2909-2914	Those	_
19-2	2915-2918	who	_
19-3	2919-2924	drink	_
19-4	2925-2932	alcohol	_
19-5	2933-2936	had	_
19-6	2937-2941	high	_
19-7	2942-2949	overall	_
19-8	2950-2960	functional	_
19-9	2961-2973	connectivity	_
19-10	2974-2975	.	_

Text=Reward-related systems, including the medial orbitofrontal cortex and the cingulate cortex, were especially strongly connected.
20-1	2976-2990	Reward-related	_
20-2	2991-2998	systems	_
20-3	2999-3000	,	_
20-4	3001-3010	including	_
20-5	3011-3014	the	_
20-6	3015-3021	medial	_
20-7	3022-3035	orbitofrontal	_
20-8	3036-3042	cortex	_
20-9	3043-3046	and	_
20-10	3047-3050	the	_
20-11	3051-3060	cingulate	_
20-12	3061-3067	cortex	_
20-13	3068-3069	,	_
20-14	3070-3074	were	_
20-15	3075-3085	especially	_
20-16	3086-3094	strongly	_
20-17	3095-3104	connected	_
20-18	3105-3106	.	_

Text=This may make them more sensitive to the rewarding aspects of drinking, or more impulsive.
21-1	3107-3111	This	_
21-2	3112-3115	may	_
21-3	3116-3120	make	_
21-4	3121-3125	them	_
21-5	3126-3130	more	_
21-6	3131-3140	sensitive	_
21-7	3141-3143	to	_
21-8	3144-3147	the	_
21-9	3148-3157	rewarding	_
21-10	3158-3165	aspects	_
21-11	3166-3168	of	_
21-12	3169-3177	drinking	_
21-13	3178-3179	,	_
21-14	3180-3182	or	_
21-15	3183-3187	more	_
21-16	3188-3197	impulsive	_
21-17	3198-3199	.	_

Text=To confirm their results, Cheng, Rolls et al.
22-1	3200-3202	To	_
22-2	3203-3210	confirm	_
22-3	3211-3216	their	_
22-4	3217-3224	results	_
22-5	3225-3226	,	_
22-6	3227-3232	Cheng	_
22-7	3233-3234	,	_
22-8	3235-3240	Rolls	_
22-9	3241-3243	et	_
22-10	3244-3246	al	_
22-11	3247-3248	.	_

Text=analyzed fMRI data from another study.
23-1	3249-3257	analyzed	_
23-2	3258-3262	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
23-3	3263-3267	data	_
23-4	3268-3272	from	_
23-5	3273-3280	another	_
23-6	3281-3286	study	_
23-7	3287-3288	.	_

Text=These showed that the characteristic differences in brain connectivity were already present in 14-year olds who would go on to drink or smoke at age 19.
24-1	3289-3294	These	_
24-2	3295-3301	showed	_
24-3	3302-3306	that	_
24-4	3307-3310	the	_
24-5	3311-3325	characteristic	_
24-6	3326-3337	differences	_
24-7	3338-3340	in	_
24-8	3341-3346	brain	_
24-9	3347-3359	connectivity	_
24-10	3360-3364	were	_
24-11	3365-3372	already	_
24-12	3373-3380	present	_
24-13	3381-3383	in	_
24-14	3384-3391	14-year	_
24-15	3392-3396	olds	_
24-16	3397-3400	who	_
24-17	3401-3406	would	_
24-18	3407-3409	go	_
24-19	3410-3412	on	_
24-20	3413-3415	to	_
24-21	3416-3421	drink	_
24-22	3422-3424	or	_
24-23	3425-3430	smoke	_
24-24	3431-3433	at	_
24-25	3434-3437	age	_
24-26	3438-3440	19	_
24-27	3441-3442	.	_

Text=This suggests that these functional connectivity differences in the brain make people more likely to smoke or drink.
25-1	3443-3447	This	_
25-2	3448-3456	suggests	_
25-3	3457-3461	that	_
25-4	3462-3467	these	_
25-5	3468-3478	functional	_
25-6	3479-3491	connectivity	_
25-7	3492-3503	differences	_
25-8	3504-3506	in	_
25-9	3507-3510	the	_
25-10	3511-3516	brain	_
25-11	3517-3521	make	_
25-12	3522-3528	people	_
25-13	3529-3533	more	_
25-14	3534-3540	likely	_
25-15	3541-3543	to	_
25-16	3544-3549	smoke	_
25-17	3550-3552	or	_
25-18	3553-3558	drink	_
25-19	3559-3560	.	_

Text=Materials and methods Participants and data preprocessing The dataset used for this investigation was selected from the November 2015 public data release from the Human Connectome Project (HCP, N = 900), WU-Minn Consortium.
26-1	3561-3570	Materials	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
26-2	3571-3574	and	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
26-3	3575-3582	methods	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
26-4	3583-3595	Participants	_
26-5	3596-3599	and	_
26-6	3600-3604	data	_
26-7	3605-3618	preprocessing	_
26-8	3619-3622	The	_
26-9	3623-3630	dataset	_
26-10	3631-3635	used	_
26-11	3636-3639	for	_
26-12	3640-3644	this	_
26-13	3645-3658	investigation	_
26-14	3659-3662	was	_
26-15	3663-3671	selected	_
26-16	3672-3676	from	_
26-17	3677-3680	the	_
26-18	3681-3689	November	_
26-19	3690-3694	2015	_
26-20	3695-3701	public	_
26-21	3702-3706	data	_
26-22	3707-3714	release	_
26-23	3715-3719	from	_
26-24	3720-3723	the	_
26-25	3724-3729	Human	_
26-26	3730-3740	Connectome	_
26-27	3741-3748	Project	_
26-28	3749-3750	(	_
26-29	3751-3754	HCP	_
26-30	3755-3756	,	_
26-31	3757-3758	N	_
26-32	3759-3760	=	_
26-33	3761-3764	900	_
26-34	3765-3766	)	_
26-35	3767-3768	,	_
26-36	3769-3776	WU-Minn	_
26-37	3777-3787	Consortium	_
26-38	3788-3789	.	_

Text=Our sample includes 831 subjects (ages 22–35 years, 463 females) scanned on a 3 T Siemens connectome-Skyra scanner.
27-1	3790-3793	Our	_
27-2	3794-3800	sample	_
27-3	3801-3809	includes	_
27-4	3810-3813	831	_
27-5	3814-3822	subjects	_
27-6	3823-3824	(	_
27-7	3825-3829	ages	_
27-8	3830-3835	22–35	_
27-9	3836-3841	years	_
27-10	3842-3843	,	_
27-11	3844-3847	463	_
27-12	3848-3855	females	_
27-13	3856-3857	)	_
27-14	3858-3865	scanned	_
27-15	3866-3868	on	_
27-16	3869-3870	a	_
27-17	3871-3872	3	_
27-18	3873-3874	T	_
27-19	3875-3882	Siemens	_
27-20	3883-3899	connectome-Skyra	http://maven.renci.org/NeuroBridge/neurobridge#ConnersRatingScaleRevised
27-21	3900-3907	scanner	http://maven.renci.org/NeuroBridge/neurobridge#ConnersRatingScaleRevised
27-22	3908-3909	.	_

Text=The HCP consortium is a public shared large-scale neuroimaging dataset which aims to map macroscopic human brain circuits and their relationship to behavior in a large population of healthy adults and which has been widely used in neuroimaging studies.
28-1	3910-3913	The	_
28-2	3914-3917	HCP	_
28-3	3918-3928	consortium	_
28-4	3929-3931	is	_
28-5	3932-3933	a	_
28-6	3934-3940	public	_
28-7	3941-3947	shared	_
28-8	3948-3959	large-scale	_
28-9	3960-3972	neuroimaging	_
28-10	3973-3980	dataset	_
28-11	3981-3986	which	_
28-12	3987-3991	aims	_
28-13	3992-3994	to	_
28-14	3995-3998	map	_
28-15	3999-4010	macroscopic	_
28-16	4011-4016	human	_
28-17	4017-4022	brain	_
28-18	4023-4031	circuits	_
28-19	4032-4035	and	_
28-20	4036-4041	their	_
28-21	4042-4054	relationship	_
28-22	4055-4057	to	_
28-23	4058-4066	behavior	_
28-24	4067-4069	in	_
28-25	4070-4071	a	_
28-26	4072-4077	large	_
28-27	4078-4088	population	_
28-28	4089-4091	of	_
28-29	4092-4099	healthy	_
28-30	4100-4106	adults	_
28-31	4107-4110	and	_
28-32	4111-4116	which	_
28-33	4117-4120	has	_
28-34	4121-4125	been	_
28-35	4126-4132	widely	_
28-36	4133-4137	used	_
28-37	4138-4140	in	_
28-38	4141-4153	neuroimaging	_
28-39	4154-4161	studies	_
28-40	4162-4163	.	_

Text=The sibships with individual having severe neurodevelopmental disorders, neuropsychiatric disorders or neurologic disorders were excluded, but individuals who are smokers, are overweight, or have a history of heavy drinking or recreational drug use without having experienced severe symptoms were included in HCP consortium.
29-1	4164-4167	The	_
29-2	4168-4176	sibships	_
29-3	4177-4181	with	_
29-4	4182-4192	individual	_
29-5	4193-4199	having	_
29-6	4200-4206	severe	_
29-7	4207-4225	neurodevelopmental	_
29-8	4226-4235	disorders	_
29-9	4236-4237	,	_
29-10	4238-4254	neuropsychiatric	_
29-11	4255-4264	disorders	_
29-12	4265-4267	or	_
29-13	4268-4278	neurologic	_
29-14	4279-4288	disorders	_
29-15	4289-4293	were	_
29-16	4294-4302	excluded	_
29-17	4303-4304	,	_
29-18	4305-4308	but	_
29-19	4309-4320	individuals	_
29-20	4321-4324	who	_
29-21	4325-4328	are	_
29-22	4329-4336	smokers	_
29-23	4337-4338	,	_
29-24	4339-4342	are	_
29-25	4343-4353	overweight	_
29-26	4354-4355	,	_
29-27	4356-4358	or	_
29-28	4359-4363	have	_
29-29	4364-4365	a	_
29-30	4366-4373	history	_
29-31	4374-4376	of	_
29-32	4377-4382	heavy	_
29-33	4383-4391	drinking	_
29-34	4392-4394	or	_
29-35	4395-4407	recreational	_
29-36	4408-4412	drug	_
29-37	4413-4416	use	_
29-38	4417-4424	without	_
29-39	4425-4431	having	_
29-40	4432-4443	experienced	_
29-41	4444-4450	severe	_
29-42	4451-4459	symptoms	_
29-43	4460-4464	were	_
29-44	4465-4473	included	_
29-45	4474-4476	in	_
29-46	4477-4480	HCP	_
29-47	4481-4491	consortium	_
29-48	4492-4493	.	_

Text=The details on the inclusion and exclusion criteria of HCP consortium were provided in the previous studies and the HCP website (https: //www.humanconnectome.org/).
30-1	4494-4497	The	_
30-2	4498-4505	details	_
30-3	4506-4508	on	_
30-4	4509-4512	the	_
30-5	4513-4522	inclusion	_
30-6	4523-4526	and	_
30-7	4527-4536	exclusion	_
30-8	4537-4545	criteria	_
30-9	4546-4548	of	_
30-10	4549-4552	HCP	_
30-11	4553-4563	consortium	_
30-12	4564-4568	were	_
30-13	4569-4577	provided	_
30-14	4578-4580	in	_
30-15	4581-4584	the	_
30-16	4585-4593	previous	_
30-17	4594-4601	studies	_
30-18	4602-4605	and	_
30-19	4606-4609	the	_
30-20	4610-4613	HCP	_
30-21	4614-4621	website	_
30-22	4622-4623	(	_
30-23	4624-4629	https	_
30-24	4630-4631	:	_
30-25	4632-4658	//www.humanconnectome.org/	_
30-26	4659-4660	)	_
30-27	4661-4662	.	_

Text=It should be noted that the HCP dataset was not specifically designed for the study of substance use, but it is useful for investigating the impact of alcohol and cigarette use in a community sample.
31-1	4663-4665	It	_
31-2	4666-4672	should	_
31-3	4673-4675	be	_
31-4	4676-4681	noted	_
31-5	4682-4686	that	_
31-6	4687-4690	the	_
31-7	4691-4694	HCP	_
31-8	4695-4702	dataset	_
31-9	4703-4706	was	_
31-10	4707-4710	not	_
31-11	4711-4723	specifically	_
31-12	4724-4732	designed	_
31-13	4733-4736	for	_
31-14	4737-4740	the	_
31-15	4741-4746	study	_
31-16	4747-4749	of	_
31-17	4750-4759	substance	_
31-18	4760-4763	use	_
31-19	4764-4765	,	_
31-20	4766-4769	but	_
31-21	4770-4772	it	_
31-22	4773-4775	is	_
31-23	4776-4782	useful	_
31-24	4783-4786	for	_
31-25	4787-4800	investigating	_
31-26	4801-4804	the	_
31-27	4805-4811	impact	_
31-28	4812-4814	of	_
31-29	4815-4822	alcohol	_
31-30	4823-4826	and	_
31-31	4827-4836	cigarette	_
31-32	4837-4840	use	_
31-33	4841-4843	in	_
31-34	4844-4845	a	_
31-35	4846-4855	community	_
31-36	4856-4862	sample	_
31-37	4863-4864	.	_

Text=Two resting state fMRI acquisitions on different days were used.
32-1	4865-4868	Two	_
32-2	4869-4876	resting	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
32-3	4877-4882	state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
32-4	4883-4887	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
32-5	4888-4900	acquisitions	_
32-6	4901-4903	on	_
32-7	4904-4913	different	_
32-8	4914-4918	days	_
32-9	4919-4923	were	_
32-10	4924-4928	used	_
32-11	4929-4930	.	_

Text=The four resting-state runs of approximately 15 min each were acquired in separate sessions on two different days, with eyes open with relaxed fixation on a projected bright cross-hair on a dark background.
33-1	4931-4934	The	_
33-2	4935-4939	four	_
33-3	4940-4953	resting-state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
33-4	4954-4958	runs	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
33-5	4959-4961	of	_
33-6	4962-4975	approximately	_
33-7	4976-4978	15	_
33-8	4979-4982	min	_
33-9	4983-4987	each	_
33-10	4988-4992	were	_
33-11	4993-5001	acquired	_
33-12	5002-5004	in	_
33-13	5005-5013	separate	_
33-14	5014-5022	sessions	_
33-15	5023-5025	on	_
33-16	5026-5029	two	_
33-17	5030-5039	different	_
33-18	5040-5044	days	_
33-19	5045-5046	,	_
33-20	5047-5051	with	_
33-21	5052-5056	eyes	_
33-22	5057-5061	open	_
33-23	5062-5066	with	_
33-24	5067-5074	relaxed	_
33-25	5075-5083	fixation	_
33-26	5084-5086	on	_
33-27	5087-5088	a	_
33-28	5089-5098	projected	_
33-29	5099-5105	bright	_
33-30	5106-5116	cross-hair	_
33-31	5117-5119	on	_
33-32	5120-5121	a	_
33-33	5122-5126	dark	_
33-34	5127-5137	background	_
33-35	5138-5139	.	_

Text=The WU-Minn HCP Consortium obtained full informed consent from all participants, and research procedures and ethical guidelines were followed in accordance with the Washington University Institutional Review Boards (IRB #201204036; Title: ‘ Mapping the Human Connectome: Structure, Function, and Heritability ’).
34-1	5140-5143	The	_
34-2	5144-5151	WU-Minn	_
34-3	5152-5155	HCP	_
34-4	5156-5166	Consortium	_
34-5	5167-5175	obtained	_
34-6	5176-5180	full	_
34-7	5181-5189	informed	_
34-8	5190-5197	consent	_
34-9	5198-5202	from	_
34-10	5203-5206	all	_
34-11	5207-5219	participants	_
34-12	5220-5221	,	_
34-13	5222-5225	and	_
34-14	5226-5234	research	_
34-15	5235-5245	procedures	_
34-16	5246-5249	and	_
34-17	5250-5257	ethical	_
34-18	5258-5268	guidelines	_
34-19	5269-5273	were	_
34-20	5274-5282	followed	_
34-21	5283-5285	in	_
34-22	5286-5296	accordance	_
34-23	5297-5301	with	_
34-24	5302-5305	the	_
34-25	5306-5316	Washington	_
34-26	5317-5327	University	_
34-27	5328-5341	Institutional	_
34-28	5342-5348	Review	_
34-29	5349-5355	Boards	_
34-30	5356-5357	(	_
34-31	5358-5361	IRB	_
34-32	5362-5363	#	_
34-33	5364-5373	201204036	_
34-34	5374-5375	;	_
34-35	5376-5381	Title	_
34-36	5382-5383	:	_
34-37	5384-5385	‘	_
34-38	5386-5393	Mapping	_
34-39	5394-5397	the	_
34-40	5398-5403	Human	_
34-41	5404-5414	Connectome	_
34-42	5415-5416	:	_
34-43	5417-5426	Structure	_
34-44	5427-5428	,	_
34-45	5429-5437	Function	_
34-46	5438-5439	,	_
34-47	5440-5443	and	_
34-48	5444-5456	Heritability	_
34-49	5457-5458	’	_
34-50	5459-5460	)	_
34-51	5461-5462	.	_

Text=The demographic characteristics of participants are summarized in Table 2.
35-1	5463-5466	The	_
35-2	5467-5478	demographic	_
35-3	5479-5494	characteristics	_
35-4	5495-5497	of	_
35-5	5498-5510	participants	_
35-6	5511-5514	are	_
35-7	5515-5525	summarized	_
35-8	5526-5528	in	_
35-9	5529-5534	Table	_
35-10	5535-5536	2	_
35-11	5537-5538	.	_

Text=More details of subjects are provided in the Supplementary Material and the collection and preprocessing of the data are provided at the HCP website (http: //www.humanconnectome.org/).
36-1	5539-5543	More	_
36-2	5544-5551	details	_
36-3	5552-5554	of	_
36-4	5555-5563	subjects	_
36-5	5564-5567	are	_
36-6	5568-5576	provided	_
36-7	5577-5579	in	_
36-8	5580-5583	the	_
36-9	5584-5597	Supplementary	_
36-10	5598-5606	Material	_
36-11	5607-5610	and	_
36-12	5611-5614	the	_
36-13	5615-5625	collection	_
36-14	5626-5629	and	_
36-15	5630-5643	preprocessing	_
36-16	5644-5646	of	_
36-17	5647-5650	the	_
36-18	5651-5655	data	_
36-19	5656-5659	are	_
36-20	5660-5668	provided	_
36-21	5669-5671	at	_
36-22	5672-5675	the	_
36-23	5676-5679	HCP	_
36-24	5680-5687	website	_
36-25	5688-5689	(	_
36-26	5690-5694	http	_
36-27	5695-5696	:	_
36-28	5697-5723	//www.humanconnectome.org/	_
36-29	5724-5725	)	_
36-30	5726-5727	.	_

Text=We obtained minimally preprocessed R-fMRI data conducted using the HCP Functional Pipeline v2.0 involving gradient distortion correction, head motion correction, image distortion correction and spatial transformation to the Montreal Neurological Institute (MNI) space using one step spline resampling from the original functional images followed by then intensity normalization.
37-1	5728-5730	We	_
37-2	5731-5739	obtained	_
37-3	5740-5749	minimally	_
37-4	5750-5762	preprocessed	_
37-5	5763-5769	R-fMRI	_
37-6	5770-5774	data	_
37-7	5775-5784	conducted	_
37-8	5785-5790	using	_
37-9	5791-5794	the	_
37-10	5795-5798	HCP	_
37-11	5799-5809	Functional	_
37-12	5810-5818	Pipeline	_
37-13	5819-5823	v2.0	_
37-14	5824-5833	involving	_
37-15	5834-5842	gradient	_
37-16	5843-5853	distortion	_
37-17	5854-5864	correction	_
37-18	5865-5866	,	_
37-19	5867-5871	head	_
37-20	5872-5878	motion	_
37-21	5879-5889	correction	_
37-22	5890-5891	,	_
37-23	5892-5897	image	_
37-24	5898-5908	distortion	_
37-25	5909-5919	correction	_
37-26	5920-5923	and	_
37-27	5924-5931	spatial	_
37-28	5932-5946	transformation	_
37-29	5947-5949	to	_
37-30	5950-5953	the	_
37-31	5954-5962	Montreal	_
37-32	5963-5975	Neurological	_
37-33	5976-5985	Institute	_
37-34	5986-5987	(	_
37-35	5988-5991	MNI	_
37-36	5992-5993	)	_
37-37	5994-5999	space	_
37-38	6000-6005	using	_
37-39	6006-6009	one	_
37-40	6010-6014	step	_
37-41	6015-6021	spline	_
37-42	6022-6032	resampling	_
37-43	6033-6037	from	_
37-44	6038-6041	the	_
37-45	6042-6050	original	_
37-46	6051-6061	functional	_
37-47	6062-6068	images	_
37-48	6069-6077	followed	_
37-49	6078-6080	by	_
37-50	6081-6085	then	_
37-51	6086-6095	intensity	_
37-52	6096-6109	normalization	_
37-53	6110-6111	.	_

Text=In this study, these minimally preprocessed images were further analyzed using FSL and AFNI.
38-1	6112-6114	In	_
38-2	6115-6119	this	_
38-3	6120-6125	study	_
38-4	6126-6127	,	_
38-5	6128-6133	these	_
38-6	6134-6143	minimally	_
38-7	6144-6156	preprocessed	_
38-8	6157-6163	images	_
38-9	6164-6168	were	_
38-10	6169-6176	further	_
38-11	6177-6185	analyzed	_
38-12	6186-6191	using	_
38-13	6192-6195	FSL	_
38-14	6196-6199	and	_
38-15	6200-6204	AFNI	_
38-16	6205-6206	.	_

Text=Briefly, first the constant, linear and quadratic trend were removed from these functional images.
39-1	6207-6214	Briefly	_
39-2	6215-6216	,	_
39-3	6217-6222	first	_
39-4	6223-6226	the	_
39-5	6227-6235	constant	_
39-6	6236-6237	,	_
39-7	6238-6244	linear	_
39-8	6245-6248	and	_
39-9	6249-6258	quadratic	_
39-10	6259-6264	trend	_
39-11	6265-6269	were	_
39-12	6270-6277	removed	_
39-13	6278-6282	from	_
39-14	6283-6288	these	_
39-15	6289-6299	functional	_
39-16	6300-6306	images	_
39-17	6307-6308	.	_

Text=Next, several nuisance signals were regressed from the time course of each voxel using multiple linear regression, including cerebrospinal fluid signal, white matter signal, and Friston ’ s 24 head motion parameters.
40-1	6309-6313	Next	_
40-2	6314-6315	,	_
40-3	6316-6323	several	_
40-4	6324-6332	nuisance	_
40-5	6333-6340	signals	_
40-6	6341-6345	were	_
40-7	6346-6355	regressed	_
40-8	6356-6360	from	_
40-9	6361-6364	the	_
40-10	6365-6369	time	_
40-11	6370-6376	course	_
40-12	6377-6379	of	_
40-13	6380-6384	each	_
40-14	6385-6390	voxel	_
40-15	6391-6396	using	_
40-16	6397-6405	multiple	_
40-17	6406-6412	linear	_
40-18	6413-6423	regression	_
40-19	6424-6425	,	_
40-20	6426-6435	including	_
40-21	6436-6449	cerebrospinal	_
40-22	6450-6455	fluid	_
40-23	6456-6462	signal	_
40-24	6463-6464	,	_
40-25	6465-6470	white	_
40-26	6471-6477	matter	_
40-27	6478-6484	signal	_
40-28	6485-6486	,	_
40-29	6487-6490	and	_
40-30	6491-6498	Friston	_
40-31	6499-6500	’	_
40-32	6501-6502	s	_
40-33	6503-6505	24	_
40-34	6506-6510	head	_
40-35	6511-6517	motion	_
40-36	6518-6528	parameters	_
40-37	6529-6530	.	_

Text=Then, temporal band-pass filtering (0.01-0.1 Hz) was performed to reduce the influence of low-frequency drift and the high-frequency physiological noise.
41-1	6531-6535	Then	_
41-2	6536-6537	,	_
41-3	6538-6546	temporal	_
41-4	6547-6556	band-pass	_
41-5	6557-6566	filtering	_
41-6	6567-6568	(	_
41-7	6569-6577	0.01-0.1	_
41-8	6578-6580	Hz	_
41-9	6581-6582	)	_
41-10	6583-6586	was	_
41-11	6587-6596	performed	_
41-12	6597-6599	to	_
41-13	6600-6606	reduce	_
41-14	6607-6610	the	_
41-15	6611-6620	influence	_
41-16	6621-6623	of	_
41-17	6624-6637	low-frequency	_
41-18	6638-6643	drift	_
41-19	6644-6647	and	_
41-20	6648-6651	the	_
41-21	6652-6666	high-frequency	_
41-22	6667-6680	physiological	_
41-23	6681-6686	noise	_
41-24	6687-6688	.	_

Text=Finally, 3D spatial smoothing is applied to each volume of the fMRI data using a Gaussian kernel with Full-width at Half Maximum (FWHM) equaling to 4 mm.
42-1	6689-6696	Finally	_
42-2	6697-6698	,	_
42-3	6699-6701	3D	_
42-4	6702-6709	spatial	_
42-5	6710-6719	smoothing	_
42-6	6720-6722	is	_
42-7	6723-6730	applied	_
42-8	6731-6733	to	_
42-9	6734-6738	each	_
42-10	6739-6745	volume	_
42-11	6746-6748	of	_
42-12	6749-6752	the	_
42-13	6753-6757	fMRI	_
42-14	6758-6762	data	_
42-15	6763-6768	using	_
42-16	6769-6770	a	_
42-17	6771-6779	Gaussian	_
42-18	6780-6786	kernel	_
42-19	6787-6791	with	_
42-20	6792-6802	Full-width	_
42-21	6803-6805	at	_
42-22	6806-6810	Half	_
42-23	6811-6818	Maximum	_
42-24	6819-6820	(	_
42-25	6821-6825	FWHM	_
42-26	6826-6827	)	_
42-27	6828-6836	equaling	_
42-28	6837-6839	to	_
42-29	6840-6841	4	_
42-30	6842-6844	mm	_
42-31	6845-6846	.	_

Text=The first 50 volumes were discarded to suppress equilibration effects and participants without the full 1200 time points in four resting-state runs were also removed from the following analysis.
43-1	6847-6850	The	_
43-2	6851-6856	first	_
43-3	6857-6859	50	_
43-4	6860-6867	volumes	_
43-5	6868-6872	were	_
43-6	6873-6882	discarded	_
43-7	6883-6885	to	_
43-8	6886-6894	suppress	_
43-9	6895-6908	equilibration	_
43-10	6909-6916	effects	_
43-11	6917-6920	and	_
43-12	6921-6933	participants	_
43-13	6934-6941	without	_
43-14	6942-6945	the	_
43-15	6946-6950	full	_
43-16	6951-6955	1200	_
43-17	6956-6960	time	_
43-18	6961-6967	points	_
43-19	6968-6970	in	_
43-20	6971-6975	four	_
43-21	6976-6989	resting-state	_
43-22	6990-6994	runs	_
43-23	6995-6999	were	_
43-24	7000-7004	also	_
43-25	7005-7012	removed	_
43-26	7013-7017	from	_
43-27	7018-7021	the	_
43-28	7022-7031	following	_
43-29	7032-7040	analysis	_
43-30	7041-7042	.	_

Text=Any data affected by head motion (mean framewise displacement larger than 0.3 mm) were excluded using the protocol of.
44-1	7043-7046	Any	_
44-2	7047-7051	data	_
44-3	7052-7060	affected	_
44-4	7061-7063	by	_
44-5	7064-7068	head	_
44-6	7069-7075	motion	_
44-7	7076-7077	(	_
44-8	7078-7082	mean	_
44-9	7083-7092	framewise	_
44-10	7093-7105	displacement	_
44-11	7106-7112	larger	_
44-12	7113-7117	than	_
44-13	7118-7121	0.3	_
44-14	7122-7124	mm	_
44-15	7125-7126	)	_
44-16	7127-7131	were	_
44-17	7132-7140	excluded	_
44-18	7141-7146	using	_
44-19	7147-7150	the	_
44-20	7151-7159	protocol	_
44-21	7160-7162	of	_
44-22	7163-7164	.	_

Text=The resulting time courses were used for the construction and analysis of the brain network.
45-1	7165-7168	The	_
45-2	7169-7178	resulting	_
45-3	7179-7183	time	_
45-4	7184-7191	courses	_
45-5	7192-7196	were	_
45-6	7197-7201	used	_
45-7	7202-7205	for	_
45-8	7206-7209	the	_
45-9	7210-7222	construction	_
45-10	7223-7226	and	_
45-11	7227-7235	analysis	_
45-12	7236-7238	of	_
45-13	7239-7242	the	_
45-14	7243-7248	brain	_
45-15	7249-7256	network	_
45-16	7257-7258	.	_

Text=We also compared the findings based on the pipeline described above and elsewhere with alternative pipelines for data preprocessing including the HCP minimal preprocessing pipeline, and our pipeline but with global signal removal.
46-1	7259-7261	We	_
46-2	7262-7266	also	_
46-3	7267-7275	compared	_
46-4	7276-7279	the	_
46-5	7280-7288	findings	_
46-6	7289-7294	based	_
46-7	7295-7297	on	_
46-8	7298-7301	the	_
46-9	7302-7310	pipeline	_
46-10	7311-7320	described	_
46-11	7321-7326	above	_
46-12	7327-7330	and	_
46-13	7331-7340	elsewhere	_
46-14	7341-7345	with	_
46-15	7346-7357	alternative	_
46-16	7358-7367	pipelines	_
46-17	7368-7371	for	_
46-18	7372-7376	data	_
46-19	7377-7390	preprocessing	_
46-20	7391-7400	including	_
46-21	7401-7404	the	_
46-22	7405-7408	HCP	_
46-23	7409-7416	minimal	_
46-24	7417-7430	preprocessing	_
46-25	7431-7439	pipeline	_
46-26	7440-7441	,	_
46-27	7442-7445	and	_
46-28	7446-7449	our	_
46-29	7450-7458	pipeline	_
46-30	7459-7462	but	_
46-31	7463-7467	with	_
46-32	7468-7474	global	_
46-33	7475-7481	signal	_
46-34	7482-7489	removal	_
46-35	7490-7491	.	_

Text=More details on the effect of the preprocessing pipelines are shown in the Supplementary Material (Figure 1—figure supplements 1).
47-1	7492-7496	More	_
47-2	7497-7504	details	_
47-3	7505-7507	on	_
47-4	7508-7511	the	_
47-5	7512-7518	effect	_
47-6	7519-7521	of	_
47-7	7522-7525	the	_
47-8	7526-7539	preprocessing	_
47-9	7540-7549	pipelines	_
47-10	7550-7553	are	_
47-11	7554-7559	shown	_
47-12	7560-7562	in	_
47-13	7563-7566	the	_
47-14	7567-7580	Supplementary	_
47-15	7581-7589	Material	_
47-16	7590-7591	(	_
47-17	7592-7598	Figure	_
47-18	7599-7607	1—figure	_
47-19	7608-7619	supplements	_
47-20	7620-7621	1	_
47-21	7622-7623	)	_
47-22	7624-7625	.	_

Text=Construction of the whole-brain functional network After preprocessing, the whole brain (gray matter) was parcellated into 94 regions of interest (ROI) according to the automated anatomical labeling (AAL2) atlas (47 regions in each hemisphere), and the time series were extracted in each ROI by averaging the signals of all voxels within that region.
48-1	7626-7638	Construction	_
48-2	7639-7641	of	_
48-3	7642-7645	the	_
48-4	7646-7657	whole-brain	_
48-5	7658-7668	functional	_
48-6	7669-7676	network	_
48-7	7677-7682	After	_
48-8	7683-7696	preprocessing	_
48-9	7697-7698	,	_
48-10	7699-7702	the	_
48-11	7703-7708	whole	_
48-12	7709-7714	brain	_
48-13	7715-7716	(	_
48-14	7717-7721	gray	_
48-15	7722-7728	matter	_
48-16	7729-7730	)	_
48-17	7731-7734	was	_
48-18	7735-7746	parcellated	_
48-19	7747-7751	into	_
48-20	7752-7754	94	_
48-21	7755-7762	regions	_
48-22	7763-7765	of	_
48-23	7766-7774	interest	_
48-24	7775-7776	(	_
48-25	7777-7780	ROI	_
48-26	7781-7782	)	_
48-27	7783-7792	according	_
48-28	7793-7795	to	_
48-29	7796-7799	the	_
48-30	7800-7809	automated	_
48-31	7810-7820	anatomical	_
48-32	7821-7829	labeling	_
48-33	7830-7831	(	_
48-34	7832-7836	AAL2	_
48-35	7837-7838	)	_
48-36	7839-7844	atlas	_
48-37	7845-7846	(	_
48-38	7847-7849	47	_
48-39	7850-7857	regions	_
48-40	7858-7860	in	_
48-41	7861-7865	each	_
48-42	7866-7876	hemisphere	_
48-43	7877-7878	)	_
48-44	7879-7880	,	_
48-45	7881-7884	and	_
48-46	7885-7888	the	_
48-47	7889-7893	time	_
48-48	7894-7900	series	_
48-49	7901-7905	were	_
48-50	7906-7915	extracted	_
48-51	7916-7918	in	_
48-52	7919-7923	each	_
48-53	7924-7927	ROI	_
48-54	7928-7930	by	_
48-55	7931-7940	averaging	_
48-56	7941-7944	the	_
48-57	7945-7952	signals	_
48-58	7953-7955	of	_
48-59	7956-7959	all	_
48-60	7960-7966	voxels	_
48-61	7967-7973	within	_
48-62	7974-7978	that	_
48-63	7979-7985	region	_
48-64	7986-7987	.	_

Text=The names of the ROIs and their corresponding abbreviations are listed in Supplementary file 1.
49-1	7988-7991	The	_
49-2	7992-7997	names	_
49-3	7998-8000	of	_
49-4	8001-8004	the	_
49-5	8005-8009	ROIs	_
49-6	8010-8013	and	_
49-7	8014-8019	their	_
49-8	8020-8033	corresponding	_
49-9	8034-8047	abbreviations	_
49-10	8048-8051	are	_
49-11	8052-8058	listed	_
49-12	8059-8061	in	_
49-13	8062-8075	Supplementary	_
49-14	8076-8080	file	_
49-15	8081-8082	1	_
49-16	8083-8084	.	_

Text=(This is a standard parcellation scheme, which provides a usable number of different divisions for statistical purposes when differences between regions are being investigated, and includes a useful parcellation of the orbitofrontal cortex .).
50-1	8085-8086	(	_
50-2	8087-8091	This	_
50-3	8092-8094	is	_
50-4	8095-8096	a	_
50-5	8097-8105	standard	_
50-6	8106-8118	parcellation	_
50-7	8119-8125	scheme	_
50-8	8126-8127	,	_
50-9	8128-8133	which	_
50-10	8134-8142	provides	_
50-11	8143-8144	a	_
50-12	8145-8151	usable	_
50-13	8152-8158	number	_
50-14	8159-8161	of	_
50-15	8162-8171	different	_
50-16	8172-8181	divisions	_
50-17	8182-8185	for	_
50-18	8186-8197	statistical	_
50-19	8198-8206	purposes	_
50-20	8207-8211	when	_
50-21	8212-8223	differences	_
50-22	8224-8231	between	_
50-23	8232-8239	regions	_
50-24	8240-8243	are	_
50-25	8244-8249	being	_
50-26	8250-8262	investigated	_
50-27	8263-8264	,	_
50-28	8265-8268	and	_
50-29	8269-8277	includes	_
50-30	8278-8279	a	_
50-31	8280-8286	useful	_
50-32	8287-8299	parcellation	_
50-33	8300-8302	of	_
50-34	8303-8306	the	_
50-35	8307-8320	orbitofrontal	_
50-36	8321-8327	cortex	_
50-37	8328-8329	.	_
50-38	8330-8331	)	_
50-39	8332-8333	.	_

Text=For comparison, we also provide the results (Figure 1—figure supplement 2) based on another atlas which has also been validated in resting state fMRI studies, although its parcellation of the orbitofrontal cortex is less good than the AAL2 atlas.
51-1	8334-8337	For	_
51-2	8338-8348	comparison	_
51-3	8349-8350	,	_
51-4	8351-8353	we	_
51-5	8354-8358	also	_
51-6	8359-8366	provide	_
51-7	8367-8370	the	_
51-8	8371-8378	results	_
51-9	8379-8380	(	_
51-10	8381-8387	Figure	_
51-11	8388-8396	1—figure	_
51-12	8397-8407	supplement	_
51-13	8408-8409	2	_
51-14	8410-8411	)	_
51-15	8412-8417	based	_
51-16	8418-8420	on	_
51-17	8421-8428	another	_
51-18	8429-8434	atlas	_
51-19	8435-8440	which	_
51-20	8441-8444	has	_
51-21	8445-8449	also	_
51-22	8450-8454	been	_
51-23	8455-8464	validated	_
51-24	8465-8467	in	_
51-25	8468-8475	resting	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
51-26	8476-8481	state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
51-27	8482-8486	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
51-28	8487-8494	studies	_
51-29	8495-8496	,	_
51-30	8497-8505	although	_
51-31	8506-8509	its	_
51-32	8510-8522	parcellation	_
51-33	8523-8525	of	_
51-34	8526-8529	the	_
51-35	8530-8543	orbitofrontal	_
51-36	8544-8550	cortex	_
51-37	8551-8553	is	_
51-38	8554-8558	less	_
51-39	8559-8563	good	_
51-40	8564-8568	than	_
51-41	8569-8572	the	_
51-42	8573-8577	AAL2	_
51-43	8578-8583	atlas	_
51-44	8584-8585	.	_

Text=The Pearson cross-correlations between all pairs of regional BOLD signals were calculated for each subject followed by z-transformation to improve normality, and the whole-brain functional connectivity network (94 × 94 region-based network with 4371 links) was constructed.
52-1	8586-8589	The	_
52-2	8590-8597	Pearson	_
52-3	8598-8616	cross-correlations	_
52-4	8617-8624	between	_
52-5	8625-8628	all	_
52-6	8629-8634	pairs	_
52-7	8635-8637	of	_
52-8	8638-8646	regional	_
52-9	8647-8651	BOLD	_
52-10	8652-8659	signals	_
52-11	8660-8664	were	_
52-12	8665-8675	calculated	_
52-13	8676-8679	for	_
52-14	8680-8684	each	_
52-15	8685-8692	subject	_
52-16	8693-8701	followed	_
52-17	8702-8704	by	_
52-18	8705-8721	z-transformation	_
52-19	8722-8724	to	_
52-20	8725-8732	improve	_
52-21	8733-8742	normality	_
52-22	8743-8744	,	_
52-23	8745-8748	and	_
52-24	8749-8752	the	_
52-25	8753-8764	whole-brain	_
52-26	8765-8775	functional	_
52-27	8776-8788	connectivity	_
52-28	8789-8796	network	_
52-29	8797-8798	(	_
52-30	8799-8801	94	_
52-31	8802-8803	×	_
52-32	8804-8806	94	_
52-33	8807-8819	region-based	_
52-34	8820-8827	network	_
52-35	8828-8832	with	_
52-36	8833-8837	4371	_
52-37	8838-8843	links	_
52-38	8844-8845	)	_
52-39	8846-8849	was	_
52-40	8850-8861	constructed	_
52-41	8862-8863	.	_

Text=Finally, the mean functional connectivity across two scans (each scan containing left to right and right to left phase encoding directions) was used for the following analysis to provide a more reliable estimation of functional connectivity.
53-1	8864-8871	Finally	_
53-2	8872-8873	,	_
53-3	8874-8877	the	_
53-4	8878-8882	mean	_
53-5	8883-8893	functional	_
53-6	8894-8906	connectivity	_
53-7	8907-8913	across	_
53-8	8914-8917	two	_
53-9	8918-8923	scans	_
53-10	8924-8925	(	_
53-11	8926-8930	each	_
53-12	8931-8935	scan	_
53-13	8936-8946	containing	_
53-14	8947-8951	left	_
53-15	8952-8954	to	_
53-16	8955-8960	right	_
53-17	8961-8964	and	_
53-18	8965-8970	right	_
53-19	8971-8973	to	_
53-20	8974-8978	left	_
53-21	8979-8984	phase	_
53-22	8985-8993	encoding	_
53-23	8994-9004	directions	_
53-24	9005-9006	)	_
53-25	9007-9010	was	_
53-26	9011-9015	used	_
53-27	9016-9019	for	_
53-28	9020-9023	the	_
53-29	9024-9033	following	_
53-30	9034-9042	analysis	_
53-31	9043-9045	to	_
53-32	9046-9053	provide	_
53-33	9054-9055	a	_
53-34	9056-9060	more	_
53-35	9061-9069	reliable	_
53-36	9070-9080	estimation	_
53-37	9081-9083	of	_
53-38	9084-9094	functional	_
53-39	9095-9107	connectivity	_
53-40	9108-9109	.	_

Text=The correlation of the functional connectivities was high between the two different scans as shown in the Supplementary Material (Figure 1—figure supplement 3).
54-1	9110-9113	The	_
54-2	9114-9125	correlation	_
54-3	9126-9128	of	_
54-4	9129-9132	the	_
54-5	9133-9143	functional	_
54-6	9144-9158	connectivities	_
54-7	9159-9162	was	_
54-8	9163-9167	high	_
54-9	9168-9175	between	_
54-10	9176-9179	the	_
54-11	9180-9183	two	_
54-12	9184-9193	different	_
54-13	9194-9199	scans	_
54-14	9200-9202	as	_
54-15	9203-9208	shown	_
54-16	9209-9211	in	_
54-17	9212-9215	the	_
54-18	9216-9229	Supplementary	_
54-19	9230-9238	Material	_
54-20	9239-9240	(	_
54-21	9241-9247	Figure	_
54-22	9248-9256	1—figure	_
54-23	9257-9267	supplement	_
54-24	9268-9269	3	_
54-25	9270-9271	)	_
54-26	9272-9273	.	_

Text=Categorization of participants into groups The following factors were considered in choosing the measures to define the groups.
55-1	9274-9288	Categorization	_
55-2	9289-9291	of	_
55-3	9292-9304	participants	_
55-4	9305-9309	into	_
55-5	9310-9316	groups	_
55-6	9317-9320	The	_
55-7	9321-9330	following	_
55-8	9331-9338	factors	_
55-9	9339-9343	were	_
55-10	9344-9354	considered	_
55-11	9355-9357	in	_
55-12	9358-9366	choosing	_
55-13	9367-9370	the	_
55-14	9371-9379	measures	_
55-15	9380-9382	to	_
55-16	9383-9389	define	_
55-17	9390-9393	the	_
55-18	9394-9400	groups	_
55-19	9401-9402	.	_

Text=The main purpose of the current study was to investigate whether there were differences in functional connectivity that were related to smoking or drinking.
56-1	9403-9406	The	_
56-2	9407-9411	main	_
56-3	9412-9419	purpose	_
56-4	9420-9422	of	_
56-5	9423-9426	the	_
56-6	9427-9434	current	_
56-7	9435-9440	study	_
56-8	9441-9444	was	_
56-9	9445-9447	to	_
56-10	9448-9459	investigate	_
56-11	9460-9467	whether	_
56-12	9468-9473	there	_
56-13	9474-9478	were	_
56-14	9479-9490	differences	_
56-15	9491-9493	in	_
56-16	9494-9504	functional	_
56-17	9505-9517	connectivity	_
56-18	9518-9522	that	_
56-19	9523-9527	were	_
56-20	9528-9535	related	_
56-21	9536-9538	to	_
56-22	9539-9546	smoking	_
56-23	9547-9549	or	_
56-24	9550-9558	drinking	_
56-25	9559-9560	.	_

Text=Accordingly, in the initial analysis, we categorized the participants for the smoking analysis into two groups, one which used significant amounts of cigarettes, and the other using no or low amounts of cigarettes.
57-1	9561-9572	Accordingly	_
57-2	9573-9574	,	_
57-3	9575-9577	in	_
57-4	9578-9581	the	_
57-5	9582-9589	initial	_
57-6	9590-9598	analysis	_
57-7	9599-9600	,	_
57-8	9601-9603	we	_
57-9	9604-9615	categorized	_
57-10	9616-9619	the	_
57-11	9620-9632	participants	_
57-12	9633-9636	for	_
57-13	9637-9640	the	_
57-14	9641-9648	smoking	_
57-15	9649-9657	analysis	_
57-16	9658-9662	into	_
57-17	9663-9666	two	_
57-18	9667-9673	groups	_
57-19	9674-9675	,	_
57-20	9676-9679	one	_
57-21	9680-9685	which	_
57-22	9686-9690	used	_
57-23	9691-9702	significant	_
57-24	9703-9710	amounts	_
57-25	9711-9713	of	_
57-26	9714-9724	cigarettes	_
57-27	9725-9726	,	_
57-28	9727-9730	and	_
57-29	9731-9734	the	_
57-30	9735-9740	other	_
57-31	9741-9746	using	_
57-32	9747-9749	no	_
57-33	9750-9752	or	_
57-34	9753-9756	low	_
57-35	9757-9764	amounts	_
57-36	9765-9767	of	_
57-37	9768-9778	cigarettes	_
57-38	9779-9780	.	_

Text=The same was performed for the division into two groups with respect to the amount of alcohol drunk.
58-1	9781-9784	The	_
58-2	9785-9789	same	_
58-3	9790-9793	was	_
58-4	9794-9803	performed	_
58-5	9804-9807	for	_
58-6	9808-9811	the	_
58-7	9812-9820	division	_
58-8	9821-9825	into	_
58-9	9826-9829	two	_
58-10	9830-9836	groups	_
58-11	9837-9841	with	_
58-12	9842-9849	respect	_
58-13	9850-9852	to	_
58-14	9853-9856	the	_
58-15	9857-9863	amount	_
58-16	9864-9866	of	_
58-17	9867-9874	alcohol	_
58-18	9875-9880	drunk	_
58-19	9881-9882	.	_

Text=In making the cutoff, we ensured that there were reasonable numbers of participants in the high and the low amount groups.
59-1	9883-9885	In	_
59-2	9886-9892	making	_
59-3	9893-9896	the	_
59-4	9897-9903	cutoff	_
59-5	9904-9905	,	_
59-6	9906-9908	we	_
59-7	9909-9916	ensured	_
59-8	9917-9921	that	_
59-9	9922-9927	there	_
59-10	9928-9932	were	_
59-11	9933-9943	reasonable	_
59-12	9944-9951	numbers	_
59-13	9952-9954	of	_
59-14	9955-9967	participants	_
59-15	9968-9970	in	_
59-16	9971-9974	the	_
59-17	9975-9979	high	_
59-18	9980-9983	and	_
59-19	9984-9987	the	_
59-20	9988-9991	low	_
59-21	9992-9998	amount	_
59-22	9999-10005	groups	_
59-23	10006-10007	.	_

Text=After the initial analysis, we wished to investigate the effect of the different amounts of use of cigarettes or alcohol, and therefore used measures of the different amounts of drinking of each participant, and the number of times each participant had smoked, as described in the results section (Figures 5 and 6).
60-1	10008-10013	After	_
60-2	10014-10017	the	_
60-3	10018-10025	initial	_
60-4	10026-10034	analysis	_
60-5	10035-10036	,	_
60-6	10037-10039	we	_
60-7	10040-10046	wished	_
60-8	10047-10049	to	_
60-9	10050-10061	investigate	_
60-10	10062-10065	the	_
60-11	10066-10072	effect	_
60-12	10073-10075	of	_
60-13	10076-10079	the	_
60-14	10080-10089	different	_
60-15	10090-10097	amounts	_
60-16	10098-10100	of	_
60-17	10101-10104	use	_
60-18	10105-10107	of	_
60-19	10108-10118	cigarettes	_
60-20	10119-10121	or	_
60-21	10122-10129	alcohol	_
60-22	10130-10131	,	_
60-23	10132-10135	and	_
60-24	10136-10145	therefore	_
60-25	10146-10150	used	_
60-26	10151-10159	measures	_
60-27	10160-10162	of	_
60-28	10163-10166	the	_
60-29	10167-10176	different	_
60-30	10177-10184	amounts	_
60-31	10185-10187	of	_
60-32	10188-10196	drinking	_
60-33	10197-10199	of	_
60-34	10200-10204	each	_
60-35	10205-10216	participant	_
60-36	10217-10218	,	_
60-37	10219-10222	and	_
60-38	10223-10226	the	_
60-39	10227-10233	number	_
60-40	10234-10236	of	_
60-41	10237-10242	times	_
60-42	10243-10247	each	_
60-43	10248-10259	participant	_
60-44	10260-10263	had	_
60-45	10264-10270	smoked	_
60-46	10271-10272	,	_
60-47	10273-10275	as	_
60-48	10276-10285	described	_
60-49	10286-10288	in	_
60-50	10289-10292	the	_
60-51	10293-10300	results	_
60-52	10301-10308	section	_
60-53	10309-10310	(	_
60-54	10311-10318	Figures	_
60-55	10319-10320	5	_
60-56	10321-10324	and	_
60-57	10325-10326	6	_
60-58	10327-10328	)	_
60-59	10329-10330	.	_

Text=Accordingly, to investigate smoking-associated functional connectivity, we divided all participants into three groups according to their smoking history (SSAGA_TB_Smoking_History), that is non-smokers (417 participants), occasional smokers (161 participants) and regular smokers (203 participants).
61-1	10331-10342	Accordingly	_
61-2	10343-10344	,	_
61-3	10345-10347	to	_
61-4	10348-10359	investigate	_
61-5	10360-10378	smoking-associated	_
61-6	10379-10389	functional	_
61-7	10390-10402	connectivity	_
61-8	10403-10404	,	_
61-9	10405-10407	we	_
61-10	10408-10415	divided	_
61-11	10416-10419	all	_
61-12	10420-10432	participants	_
61-13	10433-10437	into	_
61-14	10438-10443	three	_
61-15	10444-10450	groups	_
61-16	10451-10460	according	_
61-17	10461-10463	to	_
61-18	10464-10469	their	_
61-19	10470-10477	smoking	_
61-20	10478-10485	history	_
61-21	10486-10487	(	_
61-22	10488-10512	SSAGA_TB_Smoking_History	_
61-23	10513-10514	)	_
61-24	10515-10516	,	_
61-25	10517-10521	that	_
61-26	10522-10524	is	_
61-27	10525-10536	non-smokers	_
61-28	10537-10538	(	_
61-29	10539-10542	417	_
61-30	10543-10555	participants	_
61-31	10556-10557	)	_
61-32	10558-10559	,	_
61-33	10560-10570	occasional	_
61-34	10571-10578	smokers	_
61-35	10579-10580	(	_
61-36	10581-10584	161	_
61-37	10585-10597	participants	_
61-38	10598-10599	)	_
61-39	10600-10603	and	_
61-40	10604-10611	regular	_
61-41	10612-10619	smokers	_
61-42	10620-10621	(	_
61-43	10622-10625	203	_
61-44	10626-10638	participants	_
61-45	10639-10640	)	_
61-46	10641-10642	.	_

Text=The non-smoker group contained participants who had never smoked during their lifetime.
62-1	10643-10646	The	_
62-2	10647-10657	non-smoker	http://maven.renci.org/NeuroBridge/neurobridge#ReproductiveDisease
62-3	10658-10663	group	_
62-4	10664-10673	contained	_
62-5	10674-10686	participants	_
62-6	10687-10690	who	_
62-7	10691-10694	had	_
62-8	10695-10700	never	_
62-9	10701-10707	smoked	_
62-10	10708-10714	during	_
62-11	10715-10720	their	_
62-12	10721-10729	lifetime	_
62-13	10730-10731	.	_

Text=The occasional smoker group contained participants who experimented with cigarettes at least once in their lifetime but never became a regular smoker.
63-1	10732-10735	The	_
63-2	10736-10746	occasional	_
63-3	10747-10753	smoker	_
63-4	10754-10759	group	_
63-5	10760-10769	contained	_
63-6	10770-10782	participants	_
63-7	10783-10786	who	_
63-8	10787-10799	experimented	_
63-9	10800-10804	with	_
63-10	10805-10815	cigarettes	_
63-11	10816-10818	at	_
63-12	10819-10824	least	_
63-13	10825-10829	once	_
63-14	10830-10832	in	_
63-15	10833-10838	their	_
63-16	10839-10847	lifetime	_
63-17	10848-10851	but	_
63-18	10852-10857	never	_
63-19	10858-10864	became	_
63-20	10865-10866	a	_
63-21	10867-10874	regular	_
63-22	10875-10881	smoker	_
63-23	10882-10883	.	_

Text=The regular smoker group included those who smoked at least 100 cigarettes in his or her lifetime and smoked at least one day per week when they were smoking regularly.
64-1	10884-10887	The	_
64-2	10888-10895	regular	_
64-3	10896-10902	smoker	_
64-4	10903-10908	group	_
64-5	10909-10917	included	_
64-6	10918-10923	those	_
64-7	10924-10927	who	_
64-8	10928-10934	smoked	_
64-9	10935-10937	at	_
64-10	10938-10943	least	_
64-11	10944-10947	100	_
64-12	10948-10958	cigarettes	_
64-13	10959-10961	in	_
64-14	10962-10965	his	_
64-15	10966-10968	or	_
64-16	10969-10972	her	_
64-17	10973-10981	lifetime	_
64-18	10982-10985	and	_
64-19	10986-10992	smoked	_
64-20	10993-10995	at	_
64-21	10996-11001	least	_
64-22	11002-11005	one	_
64-23	11006-11009	day	_
64-24	11010-11013	per	_
64-25	11014-11018	week	_
64-26	11019-11023	when	_
64-27	11024-11028	they	_
64-28	11029-11033	were	_
64-29	11034-11041	smoking	_
64-30	11042-11051	regularly	_
64-31	11052-11053	.	_

Text=(A score of 3 indicates a regular smoker; of 1 and 2 indicates an occasional smoker, and 0 a non-smoker.)
65-1	11054-11055	(	_
65-2	11056-11057	A	_
65-3	11058-11063	score	_
65-4	11064-11066	of	_
65-5	11067-11068	3	_
65-6	11069-11078	indicates	_
65-7	11079-11080	a	_
65-8	11081-11088	regular	_
65-9	11089-11095	smoker	_
65-10	11096-11097	;	_
65-11	11098-11100	of	_
65-12	11101-11102	1	_
65-13	11103-11106	and	_
65-14	11107-11108	2	_
65-15	11109-11118	indicates	_
65-16	11119-11121	an	_
65-17	11122-11132	occasional	_
65-18	11133-11139	smoker	_
65-19	11140-11141	,	_
65-20	11142-11145	and	_
65-21	11146-11147	0	_
65-22	11148-11149	a	_
65-23	11150-11160	non-smoker	_
65-24	11161-11162	.	_
65-25	11163-11164	)	_

Text=In the main analyses described in this paper to investigate whether there was an effect of smoking, two of these groups were used, the non-smoker and regular smoker groups.
66-1	11165-11167	In	_
66-2	11168-11171	the	_
66-3	11172-11176	main	_
66-4	11177-11185	analyses	_
66-5	11186-11195	described	_
66-6	11196-11198	in	_
66-7	11199-11203	this	_
66-8	11204-11209	paper	_
66-9	11210-11212	to	_
66-10	11213-11224	investigate	_
66-11	11225-11232	whether	_
66-12	11233-11238	there	_
66-13	11239-11242	was	_
66-14	11243-11245	an	_
66-15	11246-11252	effect	_
66-16	11253-11255	of	_
66-17	11256-11263	smoking	_
66-18	11264-11265	,	_
66-19	11266-11269	two	_
66-20	11270-11272	of	_
66-21	11273-11278	these	_
66-22	11279-11285	groups	_
66-23	11286-11290	were	_
66-24	11291-11295	used	_
66-25	11296-11297	,	_
66-26	11298-11301	the	_
66-27	11302-11312	non-smoker	_
66-28	11313-11316	and	_
66-29	11317-11324	regular	_
66-30	11325-11331	smoker	_
66-31	11332-11338	groups	_
66-32	11339-11340	.	_

Text=The third group was helpful in further analyses to investigate effects of the amount of smoking (Figure 5).
67-1	11341-11344	The	_
67-2	11345-11350	third	_
67-3	11351-11356	group	_
67-4	11357-11360	was	_
67-5	11361-11368	helpful	_
67-6	11369-11371	in	_
67-7	11372-11379	further	_
67-8	11380-11388	analyses	_
67-9	11389-11391	to	_
67-10	11392-11403	investigate	_
67-11	11404-11411	effects	_
67-12	11412-11414	of	_
67-13	11415-11418	the	_
67-14	11419-11425	amount	_
67-15	11426-11428	of	_
67-16	11429-11436	smoking	_
67-17	11437-11438	(	_
67-18	11439-11445	Figure	_
67-19	11446-11447	5	_
67-20	11448-11449	)	_
67-21	11450-11451	.	_

Text=To investigate drinking-associated functional connectivities, we divided all participants into two groups.
68-1	11452-11454	To	_
68-2	11455-11466	investigate	_
68-3	11467-11486	drinking-associated	_
68-4	11487-11497	functional	_
68-5	11498-11512	connectivities	_
68-6	11513-11514	,	_
68-7	11515-11517	we	_
68-8	11518-11525	divided	_
68-9	11526-11529	all	_
68-10	11530-11542	participants	_
68-11	11543-11547	into	_
68-12	11548-11551	two	_
68-13	11552-11558	groups	_
68-14	11559-11560	.	_

Text=A Low Amount (LA) group with 311 participants drank one or fewer drinks per drinking day in the past 12 months.
69-1	11561-11562	A	_
69-2	11563-11566	Low	_
69-3	11567-11573	Amount	_
69-4	11574-11575	(	_
69-5	11576-11578	LA	_
69-6	11579-11580	)	_
69-7	11581-11586	group	_
69-8	11587-11591	with	_
69-9	11592-11595	311	_
69-10	11596-11608	participants	_
69-11	11609-11614	drank	_
69-12	11615-11618	one	_
69-13	11619-11621	or	_
69-14	11622-11627	fewer	_
69-15	11628-11634	drinks	_
69-16	11635-11638	per	_
69-17	11639-11647	drinking	_
69-18	11648-11651	day	_
69-19	11652-11654	in	_
69-20	11655-11658	the	_
69-21	11659-11663	past	_
69-22	11664-11666	12	_
69-23	11667-11673	months	_
69-24	11674-11675	.	_

Text=A High Amount (HA) group with 470 participants drank two or more drinks per drinking day in the past 12 months.
70-1	11676-11677	A	_
70-2	11678-11682	High	http://maven.renci.org/NeuroBridge/neurobridge#HighRisk
70-3	11683-11689	Amount	http://maven.renci.org/NeuroBridge/neurobridge#HighRisk
70-4	11690-11691	(	http://maven.renci.org/NeuroBridge/neurobridge#HighRisk
70-5	11692-11694	HA	http://maven.renci.org/NeuroBridge/neurobridge#HighRisk
70-6	11695-11696	)	http://maven.renci.org/NeuroBridge/neurobridge#HighRisk
70-7	11697-11702	group	_
70-8	11703-11707	with	_
70-9	11708-11711	470	_
70-10	11712-11724	participants	_
70-11	11725-11730	drank	_
70-12	11731-11734	two	_
70-13	11735-11737	or	_
70-14	11738-11742	more	_
70-15	11743-11749	drinks	_
70-16	11750-11753	per	_
70-17	11754-11762	drinking	_
70-18	11763-11766	day	_
70-19	11767-11769	in	_
70-20	11770-11773	the	_
70-21	11774-11778	past	_
70-22	11779-11781	12	_
70-23	11782-11788	months	_
70-24	11789-11790	.	_

Text=(The descriptor was SSAGA_Alc_12_Drinks_Per_Day, and this division into two groups was made to help comparison with the initial analysis for smokers, which also used two groups.)
71-1	11791-11792	(	_
71-2	11793-11796	The	_
71-3	11797-11807	descriptor	_
71-4	11808-11811	was	_
71-5	11812-11839	SSAGA_Alc_12_Drinks_Per_Day	_
71-6	11840-11841	,	_
71-7	11842-11845	and	_
71-8	11846-11850	this	_
71-9	11851-11859	division	_
71-10	11860-11864	into	_
71-11	11865-11868	two	_
71-12	11869-11875	groups	_
71-13	11876-11879	was	_
71-14	11880-11884	made	_
71-15	11885-11887	to	_
71-16	11888-11892	help	_
71-17	11893-11903	comparison	_
71-18	11904-11908	with	_
71-19	11909-11912	the	_
71-20	11913-11920	initial	_
71-21	11921-11929	analysis	_
71-22	11930-11933	for	_
71-23	11934-11941	smokers	_
71-24	11942-11943	,	_
71-25	11944-11949	which	_
71-26	11950-11954	also	_
71-27	11955-11959	used	_
71-28	11960-11963	two	_
71-29	11964-11970	groups	_
71-30	11971-11972	.	_
71-31	11973-11974	)	_

Text=It should be noted that the ‘ amount ’ of drinking in the current study refers to the amount of drinks per drinking day (and not for example to the total number of drinks in the past 12 months).
72-1	11975-11977	It	_
72-2	11978-11984	should	_
72-3	11985-11987	be	_
72-4	11988-11993	noted	_
72-5	11994-11998	that	_
72-6	11999-12002	the	_
72-7	12003-12004	‘	_
72-8	12005-12011	amount	_
72-9	12012-12013	’	_
72-10	12014-12016	of	_
72-11	12017-12025	drinking	_
72-12	12026-12028	in	_
72-13	12029-12032	the	_
72-14	12033-12040	current	_
72-15	12041-12046	study	_
72-16	12047-12053	refers	_
72-17	12054-12056	to	_
72-18	12057-12060	the	_
72-19	12061-12067	amount	_
72-20	12068-12070	of	_
72-21	12071-12077	drinks	_
72-22	12078-12081	per	_
72-23	12082-12090	drinking	_
72-24	12091-12094	day	_
72-25	12095-12096	(	_
72-26	12097-12100	and	_
72-27	12101-12104	not	_
72-28	12105-12108	for	_
72-29	12109-12116	example	_
72-30	12117-12119	to	_
72-31	12120-12123	the	_
72-32	12124-12129	total	_
72-33	12130-12136	number	_
72-34	12137-12139	of	_
72-35	12140-12146	drinks	_
72-36	12147-12149	in	_
72-37	12150-12153	the	_
72-38	12154-12158	past	_
72-39	12159-12161	12	_
72-40	12162-12168	months	_
72-41	12169-12170	)	_
72-42	12171-12172	.	_

Text=The rationale for the use of this measure is provided in the Discussion section, and a complementary analysis showed that there was a good correlation between the association pattern of the functional connectivities when the measures were the 'total drinks' and the 'drinks per drinking day' (r = 0.72, p <1 × 10−10).
73-1	12173-12176	The	_
73-2	12177-12186	rationale	_
73-3	12187-12190	for	_
73-4	12191-12194	the	_
73-5	12195-12198	use	_
73-6	12199-12201	of	_
73-7	12202-12206	this	_
73-8	12207-12214	measure	_
73-9	12215-12217	is	_
73-10	12218-12226	provided	_
73-11	12227-12229	in	_
73-12	12230-12233	the	_
73-13	12234-12244	Discussion	_
73-14	12245-12252	section	_
73-15	12253-12254	,	_
73-16	12255-12258	and	_
73-17	12259-12260	a	_
73-18	12261-12274	complementary	_
73-19	12275-12283	analysis	_
73-20	12284-12290	showed	_
73-21	12291-12295	that	_
73-22	12296-12301	there	_
73-23	12302-12305	was	_
73-24	12306-12307	a	_
73-25	12308-12312	good	_
73-26	12313-12324	correlation	_
73-27	12325-12332	between	_
73-28	12333-12336	the	_
73-29	12337-12348	association	_
73-30	12349-12356	pattern	_
73-31	12357-12359	of	_
73-32	12360-12363	the	_
73-33	12364-12374	functional	_
73-34	12375-12389	connectivities	_
73-35	12390-12394	when	_
73-36	12395-12398	the	_
73-37	12399-12407	measures	_
73-38	12408-12412	were	_
73-39	12413-12416	the	_
73-40	12417-12423	'total	_
73-41	12424-12430	drinks	_
73-42	12431-12432	'	_
73-43	12433-12436	and	_
73-44	12437-12440	the	_
73-45	12441-12448	'drinks	_
73-46	12449-12452	per	_
73-47	12453-12461	drinking	_
73-48	12462-12465	day	_
73-49	12466-12467	'	_
73-50	12468-12469	(	_
73-51	12470-12471	r	_
73-52	12472-12473	=	_
73-53	12474-12478	0.72	_
73-54	12479-12480	,	_
73-55	12481-12482	p	_
73-56	12483-12484	<	_
73-57	12485-12486	1	_
73-58	12487-12488	×	_
73-59	12489-12494	10−10	_
73-60	12495-12496	)	_
73-61	12497-12498	.	_

Text=In order to compare the results for smoking and drinking, only participants with information about both drinking and smoking behavior were included.
74-1	12499-12501	In	_
74-2	12502-12507	order	_
74-3	12508-12510	to	_
74-4	12511-12518	compare	_
74-5	12519-12522	the	_
74-6	12523-12530	results	_
74-7	12531-12534	for	_
74-8	12535-12542	smoking	_
74-9	12543-12546	and	_
74-10	12547-12555	drinking	_
74-11	12556-12557	,	_
74-12	12558-12562	only	_
74-13	12563-12575	participants	_
74-14	12576-12580	with	_
74-15	12581-12592	information	_
74-16	12593-12598	about	_
74-17	12599-12603	both	_
74-18	12604-12612	drinking	_
74-19	12613-12616	and	_
74-20	12617-12624	smoking	_
74-21	12625-12633	behavior	_
74-22	12634-12638	were	_
74-23	12639-12647	included	_
74-24	12648-12649	.	_

Text=The demographic characteristics of the participants in each group are summarized in Table 2.
75-1	12650-12653	The	_
75-2	12654-12665	demographic	_
75-3	12666-12681	characteristics	_
75-4	12682-12684	of	_
75-5	12685-12688	the	_
75-6	12689-12701	participants	_
75-7	12702-12704	in	_
75-8	12705-12709	each	_
75-9	12710-12715	group	_
75-10	12716-12719	are	_
75-11	12720-12730	summarized	_
75-12	12731-12733	in	_
75-13	12734-12739	Table	_
75-14	12740-12741	2	_
75-15	12742-12743	.	_

Text=Statistical analysis In order to investigate the relationship between functional connectivity (FC) and smoking, two sample two-tailed t tests were used to test whether smoking was associated with functional connectivity after removing the confounding effects of age, gender, years of education, race, handedness, head motion (mean framewise displacement, FD), BMI, blood pressure (diastolic and systolic), total gray matter volume, total white matter volume, drinking, and marijuana use.
76-1	12744-12755	Statistical	_
76-2	12756-12764	analysis	_
76-3	12765-12767	In	_
76-4	12768-12773	order	_
76-5	12774-12776	to	_
76-6	12777-12788	investigate	_
76-7	12789-12792	the	_
76-8	12793-12805	relationship	_
76-9	12806-12813	between	_
76-10	12814-12824	functional	_
76-11	12825-12837	connectivity	_
76-12	12838-12839	(	_
76-13	12840-12842	FC	_
76-14	12843-12844	)	_
76-15	12845-12848	and	_
76-16	12849-12856	smoking	_
76-17	12857-12858	,	_
76-18	12859-12862	two	_
76-19	12863-12869	sample	_
76-20	12870-12880	two-tailed	_
76-21	12881-12882	t	_
76-22	12883-12888	tests	_
76-23	12889-12893	were	_
76-24	12894-12898	used	_
76-25	12899-12901	to	_
76-26	12902-12906	test	_
76-27	12907-12914	whether	_
76-28	12915-12922	smoking	_
76-29	12923-12926	was	_
76-30	12927-12937	associated	_
76-31	12938-12942	with	_
76-32	12943-12953	functional	_
76-33	12954-12966	connectivity	_
76-34	12967-12972	after	_
76-35	12973-12981	removing	_
76-36	12982-12985	the	_
76-37	12986-12997	confounding	_
76-38	12998-13005	effects	_
76-39	13006-13008	of	_
76-40	13009-13012	age	_
76-41	13013-13014	,	_
76-42	13015-13021	gender	_
76-43	13022-13023	,	_
76-44	13024-13029	years	_
76-45	13030-13032	of	_
76-46	13033-13042	education	_
76-47	13043-13044	,	_
76-48	13045-13049	race	_
76-49	13050-13051	,	_
76-50	13052-13062	handedness	_
76-51	13063-13064	,	_
76-52	13065-13069	head	_
76-53	13070-13076	motion	_
76-54	13077-13078	(	_
76-55	13079-13083	mean	_
76-56	13084-13093	framewise	_
76-57	13094-13106	displacement	_
76-58	13107-13108	,	_
76-59	13109-13111	FD	_
76-60	13112-13113	)	_
76-61	13114-13115	,	_
76-62	13116-13119	BMI	_
76-63	13120-13121	,	_
76-64	13122-13127	blood	_
76-65	13128-13136	pressure	_
76-66	13137-13138	(	_
76-67	13139-13148	diastolic	_
76-68	13149-13152	and	_
76-69	13153-13161	systolic	_
76-70	13162-13163	)	_
76-71	13164-13165	,	_
76-72	13166-13171	total	_
76-73	13172-13176	gray	_
76-74	13177-13183	matter	_
76-75	13184-13190	volume	_
76-76	13191-13192	,	_
76-77	13193-13198	total	_
76-78	13199-13204	white	_
76-79	13205-13211	matter	_
76-80	13212-13218	volume	_
76-81	13219-13220	,	_
76-82	13221-13229	drinking	_
76-83	13230-13231	,	_
76-84	13232-13235	and	_
76-85	13236-13245	marijuana	_
76-86	13246-13249	use	_
76-87	13250-13251	.	_

Text=Considering the purpose of this study described above and the sample size in each sub-group, we used a two sample t-test rather than a 2 × 2 ANOVA.
77-1	13252-13263	Considering	_
77-2	13264-13267	the	_
77-3	13268-13275	purpose	_
77-4	13276-13278	of	_
77-5	13279-13283	this	_
77-6	13284-13289	study	_
77-7	13290-13299	described	_
77-8	13300-13305	above	_
77-9	13306-13309	and	_
77-10	13310-13313	the	_
77-11	13314-13320	sample	_
77-12	13321-13325	size	_
77-13	13326-13328	in	_
77-14	13329-13333	each	_
77-15	13334-13343	sub-group	_
77-16	13344-13345	,	_
77-17	13346-13348	we	_
77-18	13349-13353	used	_
77-19	13354-13355	a	_
77-20	13356-13359	two	_
77-21	13360-13366	sample	_
77-22	13367-13373	t-test	_
77-23	13374-13380	rather	_
77-24	13381-13385	than	_
77-25	13386-13387	a	_
77-26	13388-13389	2	_
77-27	13390-13391	×	_
77-28	13392-13393	2	_
77-29	13394-13399	ANOVA	_
77-30	13400-13401	.	_

Text=Then a Storey's FDR procedure was used to correct for multiple comparisons.
78-1	13402-13406	Then	_
78-2	13407-13408	a	_
78-3	13409-13415	Storey	_
78-4	13416-13418	's	_
78-5	13419-13422	FDR	_
78-6	13423-13432	procedure	_
78-7	13433-13436	was	_
78-8	13437-13441	used	_
78-9	13442-13444	to	_
78-10	13445-13452	correct	_
78-11	13453-13456	for	_
78-12	13457-13465	multiple	_
78-13	13466-13477	comparisons	_
78-14	13478-13479	.	_

Text=Storey ’ s FDR is a modification of FDR, also called positive False Discovery Rate (pFDR) by conditioning on one false positive finding having occurred.
79-1	13480-13486	Storey	_
79-2	13487-13488	’	_
79-3	13489-13490	s	_
79-4	13491-13494	FDR	_
79-5	13495-13497	is	_
79-6	13498-13499	a	_
79-7	13500-13512	modification	_
79-8	13513-13515	of	_
79-9	13516-13519	FDR	_
79-10	13520-13521	,	_
79-11	13522-13526	also	_
79-12	13527-13533	called	_
79-13	13534-13542	positive	_
79-14	13543-13548	False	_
79-15	13549-13558	Discovery	_
79-16	13559-13563	Rate	_
79-17	13564-13565	(	_
79-18	13566-13570	pFDR	_
79-19	13571-13572	)	_
79-20	13573-13575	by	_
79-21	13576-13588	conditioning	_
79-22	13589-13591	on	_
79-23	13592-13595	one	_
79-24	13596-13601	false	_
79-25	13602-13610	positive	_
79-26	13611-13618	finding	_
79-27	13619-13625	having	_
79-28	13626-13634	occurred	_
79-29	13635-13636	.	_

Text=The Storey's FDR method was implemented by the Matlab function mafdr.m with default parameters.
80-1	13637-13640	The	_
80-2	13641-13647	Storey	_
80-3	13648-13650	's	_
80-4	13651-13654	FDR	_
80-5	13655-13661	method	_
80-6	13662-13665	was	_
80-7	13666-13677	implemented	_
80-8	13678-13680	by	_
80-9	13681-13684	the	_
80-10	13685-13691	Matlab	_
80-11	13692-13700	function	_
80-12	13701-13708	mafdr.m	_
80-13	13709-13713	with	_
80-14	13714-13721	default	_
80-15	13722-13732	parameters	_
80-16	13733-13734	.	_

Text=In the present study FDR correction for the functional connectivity between any pair of AAL2 regions was used, and the results for smoking are presented based on this statistical test with FDR p <0.005.
81-1	13735-13737	In	_
81-2	13738-13741	the	_
81-3	13742-13749	present	_
81-4	13750-13755	study	_
81-5	13756-13759	FDR	_
81-6	13760-13770	correction	_
81-7	13771-13774	for	_
81-8	13775-13778	the	_
81-9	13779-13789	functional	_
81-10	13790-13802	connectivity	_
81-11	13803-13810	between	_
81-12	13811-13814	any	_
81-13	13815-13819	pair	_
81-14	13820-13822	of	_
81-15	13823-13827	AAL2	_
81-16	13828-13835	regions	_
81-17	13836-13839	was	_
81-18	13840-13844	used	_
81-19	13845-13846	,	_
81-20	13847-13850	and	_
81-21	13851-13854	the	_
81-22	13855-13862	results	_
81-23	13863-13866	for	_
81-24	13867-13874	smoking	_
81-25	13875-13878	are	_
81-26	13879-13888	presented	_
81-27	13889-13894	based	_
81-28	13895-13897	on	_
81-29	13898-13902	this	_
81-30	13903-13914	statistical	_
81-31	13915-13919	test	_
81-32	13920-13924	with	_
81-33	13925-13928	FDR	_
81-34	13929-13930	p	_
81-35	13931-13932	<	_
81-36	13933-13938	0.005	_
81-37	13939-13940	.	_

Text=We then performed the same statistical analysis on the high drinking and low drinking groups with the FDR correction at p <0.05.
82-1	13941-13943	We	_
82-2	13944-13948	then	_
82-3	13949-13958	performed	_
82-4	13959-13962	the	_
82-5	13963-13967	same	_
82-6	13968-13979	statistical	_
82-7	13980-13988	analysis	_
82-8	13989-13991	on	_
82-9	13992-13995	the	_
82-10	13996-14000	high	_
82-11	14001-14009	drinking	_
82-12	14010-14013	and	_
82-13	14014-14017	low	_
82-14	14018-14026	drinking	_
82-15	14027-14033	groups	_
82-16	14034-14038	with	_
82-17	14039-14042	the	_
82-18	14043-14046	FDR	_
82-19	14047-14057	correction	_
82-20	14058-14060	at	_
82-21	14061-14062	p	_
82-22	14063-14064	<	_
82-23	14065-14069	0.05	_
82-24	14070-14071	.	_

Text=The effects of any use of the other substance was always removed by regression when we performed the analysis on the use of one of the substances.
83-1	14072-14075	The	_
83-2	14076-14083	effects	_
83-3	14084-14086	of	_
83-4	14087-14090	any	_
83-5	14091-14094	use	_
83-6	14095-14097	of	_
83-7	14098-14101	the	_
83-8	14102-14107	other	_
83-9	14108-14117	substance	_
83-10	14118-14121	was	_
83-11	14122-14128	always	_
83-12	14129-14136	removed	_
83-13	14137-14139	by	_
83-14	14140-14150	regression	_
83-15	14151-14155	when	_
83-16	14156-14158	we	_
83-17	14159-14168	performed	_
83-18	14169-14172	the	_
83-19	14173-14181	analysis	_
83-20	14182-14184	on	_
83-21	14185-14188	the	_
83-22	14189-14192	use	_
83-23	14193-14195	of	_
83-24	14196-14199	one	_
83-25	14200-14202	of	_
83-26	14203-14206	the	_
83-27	14207-14217	substances	_
83-28	14218-14219	.	_

Text=For the effect of the most recent drink/cigarette use, a correlation analysis confirmed that the association pattern was highly consistent in the cases with and without the covariates of the total drinks and total times smoked in the past 7 days (r = 0.957 for smoking and r = 0.927 for drinking).
84-1	14220-14223	For	_
84-2	14224-14227	the	_
84-3	14228-14234	effect	_
84-4	14235-14237	of	_
84-5	14238-14241	the	_
84-6	14242-14246	most	_
84-7	14247-14253	recent	_
84-8	14254-14269	drink/cigarette	_
84-9	14270-14273	use	_
84-10	14274-14275	,	_
84-11	14276-14277	a	_
84-12	14278-14289	correlation	_
84-13	14290-14298	analysis	_
84-14	14299-14308	confirmed	_
84-15	14309-14313	that	_
84-16	14314-14317	the	_
84-17	14318-14329	association	_
84-18	14330-14337	pattern	_
84-19	14338-14341	was	_
84-20	14342-14348	highly	_
84-21	14349-14359	consistent	_
84-22	14360-14362	in	_
84-23	14363-14366	the	_
84-24	14367-14372	cases	_
84-25	14373-14377	with	_
84-26	14378-14381	and	_
84-27	14382-14389	without	_
84-28	14390-14393	the	_
84-29	14394-14404	covariates	_
84-30	14405-14407	of	_
84-31	14408-14411	the	_
84-32	14412-14417	total	_
84-33	14418-14424	drinks	_
84-34	14425-14428	and	_
84-35	14429-14434	total	_
84-36	14435-14440	times	_
84-37	14441-14447	smoked	_
84-38	14448-14450	in	_
84-39	14451-14454	the	_
84-40	14455-14459	past	_
84-41	14460-14461	7	_
84-42	14462-14466	days	_
84-43	14467-14468	(	_
84-44	14469-14470	r	_
84-45	14471-14472	=	_
84-46	14473-14478	0.957	_
84-47	14479-14482	for	_
84-48	14483-14490	smoking	_
84-49	14491-14494	and	_
84-50	14495-14496	r	_
84-51	14497-14498	=	_
84-52	14499-14504	0.927	_
84-53	14505-14508	for	_
84-54	14509-14517	drinking	_
84-55	14518-14519	)	_
84-56	14520-14521	.	_

Text=This provides evidence that it is whether one is a smoker or drinker that is relevant to the results described in this paper, and not just the most recent drug use.
85-1	14522-14526	This	_
85-2	14527-14535	provides	_
85-3	14536-14544	evidence	_
85-4	14545-14549	that	_
85-5	14550-14552	it	_
85-6	14553-14555	is	_
85-7	14556-14563	whether	_
85-8	14564-14567	one	_
85-9	14568-14570	is	_
85-10	14571-14572	a	_
85-11	14573-14579	smoker	_
85-12	14580-14582	or	_
85-13	14583-14590	drinker	_
85-14	14591-14595	that	_
85-15	14596-14598	is	_
85-16	14599-14607	relevant	_
85-17	14608-14610	to	_
85-18	14611-14614	the	_
85-19	14615-14622	results	_
85-20	14623-14632	described	_
85-21	14633-14635	in	_
85-22	14636-14640	this	_
85-23	14641-14646	paper	_
85-24	14647-14648	,	_
85-25	14649-14652	and	_
85-26	14653-14656	not	_
85-27	14657-14661	just	_
85-28	14662-14665	the	_
85-29	14666-14670	most	_
85-30	14671-14677	recent	_
85-31	14678-14682	drug	_
85-32	14683-14686	use	_
85-33	14687-14688	.	_

Text=Correlation of functional connectivity differences for substances with extent of use and a measure of impulsivity We explored the relationship between the functional connectivity links identified above as different in substance use groups with behavioral measures (i.e.
86-1	14689-14700	Correlation	_
86-2	14701-14703	of	_
86-3	14704-14714	functional	_
86-4	14715-14727	connectivity	_
86-5	14728-14739	differences	_
86-6	14740-14743	for	_
86-7	14744-14754	substances	_
86-8	14755-14759	with	_
86-9	14760-14766	extent	_
86-10	14767-14769	of	_
86-11	14770-14773	use	_
86-12	14774-14777	and	_
86-13	14778-14779	a	_
86-14	14780-14787	measure	_
86-15	14788-14790	of	_
86-16	14791-14802	impulsivity	_
86-17	14803-14805	We	_
86-18	14806-14814	explored	_
86-19	14815-14818	the	_
86-20	14819-14831	relationship	_
86-21	14832-14839	between	_
86-22	14840-14843	the	_
86-23	14844-14854	functional	_
86-24	14855-14867	connectivity	_
86-25	14868-14873	links	_
86-26	14874-14884	identified	_
86-27	14885-14890	above	_
86-28	14891-14893	as	_
86-29	14894-14903	different	_
86-30	14904-14906	in	_
86-31	14907-14916	substance	_
86-32	14917-14920	use	_
86-33	14921-14927	groups	_
86-34	14928-14932	with	_
86-35	14933-14943	behavioral	_
86-36	14944-14952	measures	_
86-37	14953-14954	(	_
86-38	14955-14958	i.e	_
86-39	14959-14960	.	_

Text=drinks per drinking day in the past 12 months and the amount of smoking).
87-1	14961-14967	drinks	_
87-2	14968-14971	per	_
87-3	14972-14980	drinking	_
87-4	14981-14984	day	_
87-5	14985-14987	in	_
87-6	14988-14991	the	_
87-7	14992-14996	past	_
87-8	14997-14999	12	_
87-9	15000-15006	months	_
87-10	15007-15010	and	_
87-11	15011-15014	the	_
87-12	15015-15021	amount	_
87-13	15022-15024	of	_
87-14	15025-15032	smoking	_
87-15	15033-15034	)	_
87-16	15035-15036	.	_

Text=Specifically, a partial correlation analysis was used to measure the correlation between the identified functional connectivity and these behavioral measures with removal of the confounding variables of age, gender, years of education, race, handedness, head motion (mean FD), BMI, blood pressure (diastolic and systolic), total gray matter volume, total white matter volume and use of the other substance.
88-1	15037-15049	Specifically	_
88-2	15050-15051	,	_
88-3	15052-15053	a	_
88-4	15054-15061	partial	_
88-5	15062-15073	correlation	_
88-6	15074-15082	analysis	_
88-7	15083-15086	was	_
88-8	15087-15091	used	_
88-9	15092-15094	to	_
88-10	15095-15102	measure	_
88-11	15103-15106	the	_
88-12	15107-15118	correlation	_
88-13	15119-15126	between	_
88-14	15127-15130	the	_
88-15	15131-15141	identified	_
88-16	15142-15152	functional	_
88-17	15153-15165	connectivity	_
88-18	15166-15169	and	_
88-19	15170-15175	these	_
88-20	15176-15186	behavioral	_
88-21	15187-15195	measures	_
88-22	15196-15200	with	_
88-23	15201-15208	removal	_
88-24	15209-15211	of	_
88-25	15212-15215	the	_
88-26	15216-15227	confounding	_
88-27	15228-15237	variables	_
88-28	15238-15240	of	_
88-29	15241-15244	age	_
88-30	15245-15246	,	_
88-31	15247-15253	gender	_
88-32	15254-15255	,	_
88-33	15256-15261	years	_
88-34	15262-15264	of	_
88-35	15265-15274	education	_
88-36	15275-15276	,	_
88-37	15277-15281	race	_
88-38	15282-15283	,	_
88-39	15284-15294	handedness	_
88-40	15295-15296	,	_
88-41	15297-15301	head	_
88-42	15302-15308	motion	_
88-43	15309-15310	(	_
88-44	15311-15315	mean	_
88-45	15316-15318	FD	_
88-46	15319-15320	)	_
88-47	15321-15322	,	_
88-48	15323-15326	BMI	_
88-49	15327-15328	,	_
88-50	15329-15334	blood	_
88-51	15335-15343	pressure	_
88-52	15344-15345	(	_
88-53	15346-15355	diastolic	_
88-54	15356-15359	and	_
88-55	15360-15368	systolic	_
88-56	15369-15370	)	_
88-57	15371-15372	,	_
88-58	15373-15378	total	_
88-59	15379-15383	gray	_
88-60	15384-15390	matter	_
88-61	15391-15397	volume	_
88-62	15398-15399	,	_
88-63	15400-15405	total	_
88-64	15406-15411	white	_
88-65	15412-15418	matter	_
88-66	15419-15425	volume	_
88-67	15426-15429	and	_
88-68	15430-15433	use	_
88-69	15434-15436	of	_
88-70	15437-15440	the	_
88-71	15441-15446	other	_
88-72	15447-15456	substance	_
88-73	15457-15458	.	_

Text=We also investigated the relationship between the functional connectivity links identified above as different in substance use groups and behavioral scores related to self-regulation and impulsivity.
89-1	15459-15461	We	_
89-2	15462-15466	also	_
89-3	15467-15479	investigated	_
89-4	15480-15483	the	_
89-5	15484-15496	relationship	_
89-6	15497-15504	between	_
89-7	15505-15508	the	_
89-8	15509-15519	functional	_
89-9	15520-15532	connectivity	_
89-10	15533-15538	links	_
89-11	15539-15549	identified	_
89-12	15550-15555	above	_
89-13	15556-15558	as	_
89-14	15559-15568	different	_
89-15	15569-15571	in	_
89-16	15572-15581	substance	_
89-17	15582-15585	use	_
89-18	15586-15592	groups	_
89-19	15593-15596	and	_
89-20	15597-15607	behavioral	_
89-21	15608-15614	scores	_
89-22	15615-15622	related	_
89-23	15623-15625	to	_
89-24	15626-15641	self-regulation	_
89-25	15642-15645	and	_
89-26	15646-15657	impulsivity	_
89-27	15658-15659	.	_

Text=We performed a partial correlation of the delay discounting score with the amount of drinking per drinking day and the amount of smoking respectively.
90-1	15660-15662	We	_
90-2	15663-15672	performed	_
90-3	15673-15674	a	_
90-4	15675-15682	partial	_
90-5	15683-15694	correlation	_
90-6	15695-15697	of	_
90-7	15698-15701	the	_
90-8	15702-15707	delay	_
90-9	15708-15719	discounting	_
90-10	15720-15725	score	_
90-11	15726-15730	with	_
90-12	15731-15734	the	_
90-13	15735-15741	amount	_
90-14	15742-15744	of	_
90-15	15745-15753	drinking	_
90-16	15754-15757	per	_
90-17	15758-15766	drinking	_
90-18	15767-15770	day	_
90-19	15771-15774	and	_
90-20	15775-15778	the	_
90-21	15779-15785	amount	_
90-22	15786-15788	of	_
90-23	15789-15796	smoking	_
90-24	15797-15809	respectively	_
90-25	15810-15811	.	_

Text=The score of self-regulation and impulsivity was based on the delay discounting task which measures the undervaluing of rewards delayed in time.
91-1	15812-15815	The	_
91-2	15816-15821	score	_
91-3	15822-15824	of	_
91-4	15825-15840	self-regulation	_
91-5	15841-15844	and	_
91-6	15845-15856	impulsivity	_
91-7	15857-15860	was	_
91-8	15861-15866	based	_
91-9	15867-15869	on	_
91-10	15870-15873	the	_
91-11	15874-15879	delay	_
91-12	15880-15891	discounting	_
91-13	15892-15896	task	_
91-14	15897-15902	which	_
91-15	15903-15911	measures	_
91-16	15912-15915	the	_
91-17	15916-15928	undervaluing	_
91-18	15929-15931	of	_
91-19	15932-15939	rewards	_
91-20	15940-15947	delayed	_
91-21	15948-15950	in	_
91-22	15951-15955	time	_
91-23	15956-15957	.	_

Text=We used an area-under-the-curve discounting measure (AUC) that provides a valid and reliable index of how steeply an individual discounts delayed rewards.
92-1	15958-15960	We	_
92-2	15961-15965	used	_
92-3	15966-15968	an	_
92-4	15969-15989	area-under-the-curve	_
92-5	15990-16001	discounting	_
92-6	16002-16009	measure	_
92-7	16010-16011	(	_
92-8	16012-16015	AUC	_
92-9	16016-16017	)	_
92-10	16018-16022	that	_
92-11	16023-16031	provides	_
92-12	16032-16033	a	_
92-13	16034-16039	valid	_
92-14	16040-16043	and	_
92-15	16044-16052	reliable	_
92-16	16053-16058	index	_
92-17	16059-16061	of	_
92-18	16062-16065	how	_
92-19	16066-16073	steeply	_
92-20	16074-16076	an	_
92-21	16077-16087	individual	_
92-22	16088-16097	discounts	_
92-23	16098-16105	delayed	_
92-24	16106-16113	rewards	_
92-25	16114-16115	.	_

Text=Specifically, we calculated the canonical correlation between the area under the curve for discounting of $200 and $40,000 (DDisc_AUC_200 and DDisc_AUC_40K) with the strength of associated functional connectivities for drinking and smoking respectively, after removing the effects of age, gender, years of education, race, handedness, head motion (mean FD), BMI, blood pressure (diastolic and systolic) total gray matter volume, total white matter volume and use of the other two substances.
93-1	16116-16128	Specifically	_
93-2	16129-16130	,	_
93-3	16131-16133	we	_
93-4	16134-16144	calculated	_
93-5	16145-16148	the	_
93-6	16149-16158	canonical	_
93-7	16159-16170	correlation	_
93-8	16171-16178	between	_
93-9	16179-16182	the	_
93-10	16183-16187	area	_
93-11	16188-16193	under	_
93-12	16194-16197	the	_
93-13	16198-16203	curve	_
93-14	16204-16207	for	_
93-15	16208-16219	discounting	_
93-16	16220-16222	of	_
93-17	16223-16224	$	_
93-18	16225-16228	200	_
93-19	16229-16232	and	_
93-20	16233-16234	$	_
93-21	16235-16241	40,000	_
93-22	16242-16243	(	_
93-23	16244-16257	DDisc_AUC_200	_
93-24	16258-16261	and	_
93-25	16262-16275	DDisc_AUC_40K	_
93-26	16276-16277	)	_
93-27	16278-16282	with	_
93-28	16283-16286	the	_
93-29	16287-16295	strength	_
93-30	16296-16298	of	_
93-31	16299-16309	associated	_
93-32	16310-16320	functional	_
93-33	16321-16335	connectivities	_
93-34	16336-16339	for	_
93-35	16340-16348	drinking	_
93-36	16349-16352	and	_
93-37	16353-16360	smoking	_
93-38	16361-16373	respectively	_
93-39	16374-16375	,	_
93-40	16376-16381	after	_
93-41	16382-16390	removing	_
93-42	16391-16394	the	_
93-43	16395-16402	effects	_
93-44	16403-16405	of	_
93-45	16406-16409	age	_
93-46	16410-16411	,	_
93-47	16412-16418	gender	_
93-48	16419-16420	,	_
93-49	16421-16426	years	_
93-50	16427-16429	of	_
93-51	16430-16439	education	_
93-52	16440-16441	,	_
93-53	16442-16446	race	_
93-54	16447-16448	,	_
93-55	16449-16459	handedness	_
93-56	16460-16461	,	_
93-57	16462-16466	head	_
93-58	16467-16473	motion	_
93-59	16474-16475	(	_
93-60	16476-16480	mean	_
93-61	16481-16483	FD	_
93-62	16484-16485	)	_
93-63	16486-16487	,	_
93-64	16488-16491	BMI	_
93-65	16492-16493	,	_
93-66	16494-16499	blood	_
93-67	16500-16508	pressure	_
93-68	16509-16510	(	_
93-69	16511-16520	diastolic	_
93-70	16521-16524	and	_
93-71	16525-16533	systolic	_
93-72	16534-16535	)	_
93-73	16536-16541	total	_
93-74	16542-16546	gray	_
93-75	16547-16553	matter	_
93-76	16554-16560	volume	_
93-77	16561-16562	,	_
93-78	16563-16568	total	_
93-79	16569-16574	white	_
93-80	16575-16581	matter	_
93-81	16582-16588	volume	_
93-82	16589-16592	and	_
93-83	16593-16596	use	_
93-84	16597-16599	of	_
93-85	16600-16603	the	_
93-86	16604-16609	other	_
93-87	16610-16613	two	_
93-88	16614-16624	substances	_
93-89	16625-16626	.	_

Text=Cross-validation with the IMAGEN dataset We used another separate large longitudinal fMRI dataset (the IMAGEN dataset) which included 1176 participants to test whether the findings based on the HCP dataset could be cross-validated with an independent dataset, which would considerably strengthen the findings.
94-1	16627-16643	Cross-validation	_
94-2	16644-16648	with	_
94-3	16649-16652	the	_
94-4	16653-16659	IMAGEN	_
94-5	16660-16667	dataset	_
94-6	16668-16670	We	_
94-7	16671-16675	used	_
94-8	16676-16683	another	_
94-9	16684-16692	separate	_
94-10	16693-16698	large	_
94-11	16699-16711	longitudinal	_
94-12	16712-16716	fMRI	_
94-13	16717-16724	dataset	_
94-14	16725-16726	(	_
94-15	16727-16730	the	_
94-16	16731-16737	IMAGEN	_
94-17	16738-16745	dataset	_
94-18	16746-16747	)	_
94-19	16748-16753	which	_
94-20	16754-16762	included	_
94-21	16763-16767	1176	_
94-22	16768-16780	participants	_
94-23	16781-16783	to	_
94-24	16784-16788	test	_
94-25	16789-16796	whether	_
94-26	16797-16800	the	_
94-27	16801-16809	findings	_
94-28	16810-16815	based	_
94-29	16816-16818	on	_
94-30	16819-16822	the	_
94-31	16823-16826	HCP	_
94-32	16827-16834	dataset	_
94-33	16835-16840	could	_
94-34	16841-16843	be	_
94-35	16844-16859	cross-validated	_
94-36	16860-16864	with	_
94-37	16865-16867	an	_
94-38	16868-16879	independent	_
94-39	16880-16887	dataset	_
94-40	16888-16889	,	_
94-41	16890-16895	which	_
94-42	16896-16901	would	_
94-43	16902-16914	considerably	_
94-44	16915-16925	strengthen	_
94-45	16926-16929	the	_
94-46	16930-16938	findings	_
94-47	16939-16940	.	_

Text=This dataset also enabled examination of whether functional connectivity at age 14 when participants neither smoke nor drank was associated with who would become drinkers or smokers at age 19.
95-1	16941-16945	This	_
95-2	16946-16953	dataset	_
95-3	16954-16958	also	_
95-4	16959-16966	enabled	_
95-5	16967-16978	examination	_
95-6	16979-16981	of	_
95-7	16982-16989	whether	_
95-8	16990-17000	functional	_
95-9	17001-17013	connectivity	_
95-10	17014-17016	at	_
95-11	17017-17020	age	_
95-12	17021-17023	14	_
95-13	17024-17028	when	_
95-14	17029-17041	participants	_
95-15	17042-17049	neither	_
95-16	17050-17055	smoke	_
95-17	17056-17059	nor	_
95-18	17060-17065	drank	_
95-19	17066-17069	was	_
95-20	17070-17080	associated	_
95-21	17081-17085	with	_
95-22	17086-17089	who	_
95-23	17090-17095	would	_
95-24	17096-17102	become	_
95-25	17103-17111	drinkers	_
95-26	17112-17114	or	_
95-27	17115-17122	smokers	_
95-28	17123-17125	at	_
95-29	17126-17129	age	_
95-30	17130-17132	19	_
95-31	17133-17134	.	_

Text=This potentially thus provides a way to investigate whether differences between individuals that were not caused by smoking and drinking (as there was little smoking and drinking when the participants were 14) might lead to smoking or drinking by the time that the participants were 19.
96-1	17135-17139	This	_
96-2	17140-17151	potentially	_
96-3	17152-17156	thus	_
96-4	17157-17165	provides	_
96-5	17166-17167	a	_
96-6	17168-17171	way	_
96-7	17172-17174	to	_
96-8	17175-17186	investigate	_
96-9	17187-17194	whether	_
96-10	17195-17206	differences	_
96-11	17207-17214	between	_
96-12	17215-17226	individuals	_
96-13	17227-17231	that	_
96-14	17232-17236	were	_
96-15	17237-17240	not	_
96-16	17241-17247	caused	_
96-17	17248-17250	by	_
96-18	17251-17258	smoking	_
96-19	17259-17262	and	_
96-20	17263-17271	drinking	_
96-21	17272-17273	(	_
96-22	17274-17276	as	_
96-23	17277-17282	there	_
96-24	17283-17286	was	_
96-25	17287-17293	little	_
96-26	17294-17301	smoking	_
96-27	17302-17305	and	_
96-28	17306-17314	drinking	_
96-29	17315-17319	when	_
96-30	17320-17323	the	_
96-31	17324-17336	participants	_
96-32	17337-17341	were	_
96-33	17342-17344	14	_
96-34	17345-17346	)	_
96-35	17347-17352	might	_
96-36	17353-17357	lead	_
96-37	17358-17360	to	_
96-38	17361-17368	smoking	_
96-39	17369-17371	or	_
96-40	17372-17380	drinking	_
96-41	17381-17383	by	_
96-42	17384-17387	the	_
96-43	17388-17392	time	_
96-44	17393-17397	that	_
96-45	17398-17401	the	_
96-46	17402-17414	participants	_
96-47	17415-17419	were	_
96-48	17420-17422	19	_
96-49	17423-17424	.	_

Text=The IMAGEN dataset also enabled investigation of gender differences in the behaviors that may be predictable from brain functional connectivity in this important period of development.
97-1	17425-17428	The	_
97-2	17429-17435	IMAGEN	_
97-3	17436-17443	dataset	_
97-4	17444-17448	also	_
97-5	17449-17456	enabled	_
97-6	17457-17470	investigation	_
97-7	17471-17473	of	_
97-8	17474-17480	gender	_
97-9	17481-17492	differences	_
97-10	17493-17495	in	_
97-11	17496-17499	the	_
97-12	17500-17509	behaviors	_
97-13	17510-17514	that	_
97-14	17515-17518	may	_
97-15	17519-17521	be	_
97-16	17522-17533	predictable	_
97-17	17534-17538	from	_
97-18	17539-17544	brain	_
97-19	17545-17555	functional	_
97-20	17556-17568	connectivity	_
97-21	17569-17571	in	_
97-22	17572-17576	this	_
97-23	17577-17586	important	_
97-24	17587-17593	period	_
97-25	17594-17596	of	_
97-26	17597-17608	development	_
97-27	17609-17610	.	_

Text=The details of demographic characteristics of participants from the IMAGEN dataset are presented in Supplementary file 2.
98-1	17611-17614	The	_
98-2	17615-17622	details	_
98-3	17623-17625	of	_
98-4	17626-17637	demographic	_
98-5	17638-17653	characteristics	_
98-6	17654-17656	of	_
98-7	17657-17669	participants	_
98-8	17670-17674	from	_
98-9	17675-17678	the	_
98-10	17679-17685	IMAGEN	_
98-11	17686-17693	dataset	_
98-12	17694-17697	are	_
98-13	17698-17707	presented	_
98-14	17708-17710	in	_
98-15	17711-17724	Supplementary	_
98-16	17725-17729	file	_
98-17	17730-17731	2	_
98-18	17732-17733	.	_

Text=Participants IMAGEN adopted a longitudinal design to collect genetic, neuroimaging, environmental, and behavioural data in the UK and Europe, starting at age 14 years old with a sample 2087 healthy adolescents, and followed at ages 16 and 19 years.
99-1	17734-17746	Participants	_
99-2	17747-17753	IMAGEN	_
99-3	17754-17761	adopted	_
99-4	17762-17763	a	_
99-5	17764-17776	longitudinal	_
99-6	17777-17783	design	_
99-7	17784-17786	to	_
99-8	17787-17794	collect	_
99-9	17795-17802	genetic	_
99-10	17803-17804	,	_
99-11	17805-17817	neuroimaging	_
99-12	17818-17819	,	_
99-13	17820-17833	environmental	_
99-14	17834-17835	,	_
99-15	17836-17839	and	_
99-16	17840-17851	behavioural	_
99-17	17852-17856	data	_
99-18	17857-17859	in	_
99-19	17860-17863	the	_
99-20	17864-17866	UK	_
99-21	17867-17870	and	_
99-22	17871-17877	Europe	_
99-23	17878-17879	,	_
99-24	17880-17888	starting	_
99-25	17889-17891	at	_
99-26	17892-17895	age	_
99-27	17896-17898	14	_
99-28	17899-17904	years	_
99-29	17905-17908	old	_
99-30	17909-17913	with	_
99-31	17914-17915	a	_
99-32	17916-17922	sample	_
99-33	17923-17927	2087	_
99-34	17928-17935	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
99-35	17936-17947	adolescents	_
99-36	17948-17949	,	_
99-37	17950-17953	and	_
99-38	17954-17962	followed	_
99-39	17963-17965	at	_
99-40	17966-17970	ages	_
99-41	17971-17973	16	_
99-42	17974-17977	and	_
99-43	17978-17980	19	_
99-44	17981-17986	years	_
99-45	17987-17988	.	_

Text=The neuroimaging data were acquired at ages 14 and 19 years.
100-1	17989-17992	The	_
100-2	17993-18005	neuroimaging	_
100-3	18006-18010	data	_
100-4	18011-18015	were	_
100-5	18016-18024	acquired	_
100-6	18025-18027	at	_
100-7	18028-18032	ages	_
100-8	18033-18035	14	_
100-9	18036-18039	and	_
100-10	18040-18042	19	_
100-11	18043-18048	years	_
100-12	18049-18050	.	_

Text=The demographic characteristics of participants who included resting state fMRI scans are summarized in Supplementary file 2.
101-1	18051-18054	The	_
101-2	18055-18066	demographic	_
101-3	18067-18082	characteristics	_
101-4	18083-18085	of	_
101-5	18086-18098	participants	_
101-6	18099-18102	who	_
101-7	18103-18111	included	_
101-8	18112-18119	resting	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
101-9	18120-18125	state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
101-10	18126-18130	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
101-11	18131-18136	scans	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
101-12	18137-18140	are	_
101-13	18141-18151	summarized	_
101-14	18152-18154	in	_
101-15	18155-18168	Supplementary	_
101-16	18169-18173	file	_
101-17	18174-18175	2	_
101-18	18176-18177	.	_

Text=IMAGEN 19: For the dataset at age 19, by using a similar criterion to define the sub-groups as in the HCP database, a Low Amount (LA) drinking group with 378 participants who drank two or fewer drinks per drinking day, and a High Amount (HA) drinking group with 566 participants who drank three or more drinks per drinking day, were identified.
102-1	18178-18184	IMAGEN	_
102-2	18185-18187	19	_
102-3	18188-18189	:	_
102-4	18190-18193	For	_
102-5	18194-18197	the	_
102-6	18198-18205	dataset	_
102-7	18206-18208	at	_
102-8	18209-18212	age	_
102-9	18213-18215	19	_
102-10	18216-18217	,	_
102-11	18218-18220	by	_
102-12	18221-18226	using	_
102-13	18227-18228	a	_
102-14	18229-18236	similar	_
102-15	18237-18246	criterion	_
102-16	18247-18249	to	_
102-17	18250-18256	define	_
102-18	18257-18260	the	_
102-19	18261-18271	sub-groups	_
102-20	18272-18274	as	_
102-21	18275-18277	in	_
102-22	18278-18281	the	_
102-23	18282-18285	HCP	_
102-24	18286-18294	database	_
102-25	18295-18296	,	_
102-26	18297-18298	a	_
102-27	18299-18302	Low	_
102-28	18303-18309	Amount	_
102-29	18310-18311	(	_
102-30	18312-18314	LA	_
102-31	18315-18316	)	_
102-32	18317-18325	drinking	_
102-33	18326-18331	group	_
102-34	18332-18336	with	_
102-35	18337-18340	378	_
102-36	18341-18353	participants	_
102-37	18354-18357	who	_
102-38	18358-18363	drank	_
102-39	18364-18367	two	_
102-40	18368-18370	or	_
102-41	18371-18376	fewer	_
102-42	18377-18383	drinks	_
102-43	18384-18387	per	_
102-44	18388-18396	drinking	_
102-45	18397-18400	day	_
102-46	18401-18402	,	_
102-47	18403-18406	and	_
102-48	18407-18408	a	_
102-49	18409-18413	High	_
102-50	18414-18420	Amount	_
102-51	18421-18422	(	_
102-52	18423-18425	HA	_
102-53	18426-18427	)	_
102-54	18428-18436	drinking	_
102-55	18437-18442	group	_
102-56	18443-18447	with	_
102-57	18448-18451	566	_
102-58	18452-18464	participants	_
102-59	18465-18468	who	_
102-60	18469-18474	drank	_
102-61	18475-18480	three	_
102-62	18481-18483	or	_
102-63	18484-18488	more	_
102-64	18489-18495	drinks	_
102-65	18496-18499	per	_
102-66	18500-18508	drinking	_
102-67	18509-18512	day	_
102-68	18513-18514	,	_
102-69	18515-18519	were	_
102-70	18520-18530	identified	_
102-71	18531-18532	.	_

Text=The small difference in the different definitions for the drinking groups for the HCP and IMAGEN samples is because they used different questionnaires.
103-1	18533-18536	The	_
103-2	18537-18542	small	_
103-3	18543-18553	difference	_
103-4	18554-18556	in	_
103-5	18557-18560	the	_
103-6	18561-18570	different	_
103-7	18571-18582	definitions	_
103-8	18583-18586	for	_
103-9	18587-18590	the	_
103-10	18591-18599	drinking	_
103-11	18600-18606	groups	_
103-12	18607-18610	for	_
103-13	18611-18614	the	_
103-14	18615-18618	HCP	_
103-15	18619-18622	and	_
103-16	18623-18629	IMAGEN	_
103-17	18630-18637	samples	_
103-18	18638-18640	is	_
103-19	18641-18648	because	_
103-20	18649-18653	they	_
103-21	18654-18658	used	_
103-22	18659-18668	different	_
103-23	18669-18683	questionnaires	_
103-24	18684-18685	.	_

Text=We used the European School Survey Project on Alcohol and Other Drugs (ESPAD) to assess the lifetime drinking and smoking in the IMAGEN dataset.
104-1	18686-18688	We	_
104-2	18689-18693	used	_
104-3	18694-18697	the	_
104-4	18698-18706	European	_
104-5	18707-18713	School	_
104-6	18714-18720	Survey	_
104-7	18721-18728	Project	_
104-8	18729-18731	on	_
104-9	18732-18739	Alcohol	http://maven.renci.org/NeuroBridge/neurobridge#ExtrapyramidalDisease
104-10	18740-18743	and	http://maven.renci.org/NeuroBridge/neurobridge#ExtrapyramidalDisease
104-11	18744-18749	Other	http://maven.renci.org/NeuroBridge/neurobridge#ExtrapyramidalDisease
104-12	18750-18755	Drugs	http://maven.renci.org/NeuroBridge/neurobridge#ExtrapyramidalDisease
104-13	18756-18757	(	_
104-14	18758-18763	ESPAD	_
104-15	18764-18765	)	_
104-16	18766-18768	to	_
104-17	18769-18775	assess	_
104-18	18776-18779	the	_
104-19	18780-18788	lifetime	_
104-20	18789-18797	drinking	_
104-21	18798-18801	and	_
104-22	18802-18809	smoking	_
104-23	18810-18812	in	_
104-24	18813-18816	the	_
104-25	18817-18823	IMAGEN	_
104-26	18824-18831	dataset	_
104-27	18832-18833	.	_

Text=The measure of drinking in the IMAGEN dataset is as follows: “ How many drinks containing alcohol do you have on a typical day when you are drinking?
105-1	18834-18837	The	_
105-2	18838-18845	measure	_
105-3	18846-18848	of	_
105-4	18849-18857	drinking	_
105-5	18858-18860	in	_
105-6	18861-18864	the	_
105-7	18865-18871	IMAGEN	_
105-8	18872-18879	dataset	_
105-9	18880-18882	is	_
105-10	18883-18885	as	_
105-11	18886-18893	follows	_
105-12	18894-18895	:	_
105-13	18896-18897	“	_
105-14	18898-18901	How	_
105-15	18902-18906	many	_
105-16	18907-18913	drinks	_
105-17	18914-18924	containing	_
105-18	18925-18932	alcohol	_
105-19	18933-18935	do	_
105-20	18936-18939	you	_
105-21	18940-18944	have	_
105-22	18945-18947	on	_
105-23	18948-18949	a	_
105-24	18950-18957	typical	_
105-25	18958-18961	day	_
105-26	18962-18966	when	_
105-27	18967-18970	you	_
105-28	18971-18974	are	_
105-29	18975-18983	drinking	_
105-30	18984-18985	?	_

Text=1: 1 or 2 2: 3 or 4 3: 5 or 6 4: 7 to 9 5: 10 or more ’ For comparison, the measure of drinking in the HCP dataset is: ‘ Drinks consumed per drinking day in past 12 months: 0, 1, 2, 3, 4, 5–6 = 5, 7+ = 6. ’ In fact, the control group for the HCP and IMAGEN datasets were similar, in that they had not drunk alcohol.
106-1	18986-18987	1	_
106-2	18988-18989	:	_
106-3	18990-18991	1	_
106-4	18992-18994	or	_
106-5	18995-18996	2	_
106-6	18997-18998	2	_
106-7	18999-19000	:	_
106-8	19001-19002	3	_
106-9	19003-19005	or	_
106-10	19006-19007	4	_
106-11	19008-19009	3	_
106-12	19010-19011	:	_
106-13	19012-19013	5	_
106-14	19014-19016	or	_
106-15	19017-19018	6	_
106-16	19019-19020	4	_
106-17	19021-19022	:	_
106-18	19023-19024	7	_
106-19	19025-19027	to	_
106-20	19028-19029	9	_
106-21	19030-19031	5	_
106-22	19032-19033	:	_
106-23	19034-19036	10	_
106-24	19037-19039	or	_
106-25	19040-19044	more	_
106-26	19045-19046	’	_
106-27	19047-19050	For	_
106-28	19051-19061	comparison	_
106-29	19062-19063	,	_
106-30	19064-19067	the	_
106-31	19068-19075	measure	_
106-32	19076-19078	of	_
106-33	19079-19087	drinking	_
106-34	19088-19090	in	_
106-35	19091-19094	the	_
106-36	19095-19098	HCP	_
106-37	19099-19106	dataset	_
106-38	19107-19109	is	_
106-39	19110-19111	:	_
106-40	19112-19113	‘	_
106-41	19114-19120	Drinks	_
106-42	19121-19129	consumed	_
106-43	19130-19133	per	_
106-44	19134-19142	drinking	_
106-45	19143-19146	day	_
106-46	19147-19149	in	_
106-47	19150-19154	past	_
106-48	19155-19157	12	_
106-49	19158-19164	months	_
106-50	19165-19166	:	_
106-51	19167-19168	0	_
106-52	19169-19170	,	_
106-53	19171-19172	1	_
106-54	19173-19174	,	_
106-55	19175-19176	2	_
106-56	19177-19178	,	_
106-57	19179-19180	3	_
106-58	19181-19182	,	_
106-59	19183-19184	4	_
106-60	19185-19186	,	_
106-61	19187-19190	5–6	_
106-62	19191-19192	=	_
106-63	19193-19194	5	_
106-64	19195-19196	,	_
106-65	19197-19199	7+	_
106-66	19200-19201	=	_
106-67	19202-19204	6.	_
106-68	19205-19206	’	_
106-69	19207-19209	In	_
106-70	19210-19214	fact	_
106-71	19215-19216	,	_
106-72	19217-19220	the	_
106-73	19221-19228	control	_
106-74	19229-19234	group	_
106-75	19235-19238	for	_
106-76	19239-19242	the	_
106-77	19243-19246	HCP	_
106-78	19247-19250	and	_
106-79	19251-19257	IMAGEN	_
106-80	19258-19266	datasets	_
106-81	19267-19271	were	_
106-82	19272-19279	similar	_
106-83	19280-19281	,	_
106-84	19282-19284	in	_
106-85	19285-19289	that	_
106-86	19290-19294	they	_
106-87	19295-19298	had	_
106-88	19299-19302	not	_
106-89	19303-19308	drunk	_
106-90	19309-19316	alcohol	_
106-91	19317-19318	.	_

Text=For the smoking dataset, a smoking group (regular smoker) was defined as those who smoked at least 100 cigarettes in his or her lifetime and smoked at least one day per week when they were smoking regularly (180 participants), and a non-smoking group (who had never smoked, 295 participants).
107-1	19319-19322	For	_
107-2	19323-19326	the	_
107-3	19327-19334	smoking	_
107-4	19335-19342	dataset	_
107-5	19343-19344	,	_
107-6	19345-19346	a	_
107-7	19347-19354	smoking	_
107-8	19355-19360	group	_
107-9	19361-19362	(	_
107-10	19363-19370	regular	_
107-11	19371-19377	smoker	_
107-12	19378-19379	)	_
107-13	19380-19383	was	_
107-14	19384-19391	defined	_
107-15	19392-19394	as	_
107-16	19395-19400	those	_
107-17	19401-19404	who	_
107-18	19405-19411	smoked	_
107-19	19412-19414	at	_
107-20	19415-19420	least	_
107-21	19421-19424	100	_
107-22	19425-19435	cigarettes	_
107-23	19436-19438	in	_
107-24	19439-19442	his	_
107-25	19443-19445	or	_
107-26	19446-19449	her	_
107-27	19450-19458	lifetime	_
107-28	19459-19462	and	_
107-29	19463-19469	smoked	_
107-30	19470-19472	at	_
107-31	19473-19478	least	_
107-32	19479-19482	one	_
107-33	19483-19486	day	_
107-34	19487-19490	per	_
107-35	19491-19495	week	_
107-36	19496-19500	when	_
107-37	19501-19505	they	_
107-38	19506-19510	were	_
107-39	19511-19518	smoking	_
107-40	19519-19528	regularly	_
107-41	19529-19530	(	_
107-42	19531-19534	180	_
107-43	19535-19547	participants	_
107-44	19548-19549	)	_
107-45	19550-19551	,	_
107-46	19552-19555	and	_
107-47	19556-19557	a	_
107-48	19558-19569	non-smoking	_
107-49	19570-19575	group	_
107-50	19576-19577	(	_
107-51	19578-19581	who	_
107-52	19582-19585	had	_
107-53	19586-19591	never	_
107-54	19592-19598	smoked	_
107-55	19599-19600	,	_
107-56	19601-19604	295	_
107-57	19605-19617	participants	_
107-58	19618-19619	)	_
107-59	19620-19621	.	_

Text=IMAGEN 14: Since almost all participants did not take any cigarettes and alcohol at age 14, it was not suitable to assess the difference between smoking and non-smoking group (or low drinking and high drinking group).
108-1	19622-19628	IMAGEN	_
108-2	19629-19631	14	_
108-3	19632-19633	:	_
108-4	19634-19639	Since	_
108-5	19640-19646	almost	_
108-6	19647-19650	all	_
108-7	19651-19663	participants	_
108-8	19664-19667	did	_
108-9	19668-19671	not	_
108-10	19672-19676	take	_
108-11	19677-19680	any	_
108-12	19681-19691	cigarettes	_
108-13	19692-19695	and	_
108-14	19696-19703	alcohol	_
108-15	19704-19706	at	_
108-16	19707-19710	age	_
108-17	19711-19713	14	_
108-18	19714-19715	,	_
108-19	19716-19718	it	_
108-20	19719-19722	was	_
108-21	19723-19726	not	_
108-22	19727-19735	suitable	_
108-23	19736-19738	to	_
108-24	19739-19745	assess	_
108-25	19746-19749	the	_
108-26	19750-19760	difference	_
108-27	19761-19768	between	_
108-28	19769-19776	smoking	_
108-29	19777-19780	and	_
108-30	19781-19792	non-smoking	_
108-31	19793-19798	group	_
108-32	19799-19800	(	_
108-33	19801-19803	or	_
108-34	19804-19807	low	_
108-35	19808-19816	drinking	_
108-36	19817-19820	and	_
108-37	19821-19825	high	_
108-38	19826-19834	drinking	_
108-39	19835-19840	group	_
108-40	19841-19842	)	_
108-41	19843-19844	.	_

Text=However, this longitudinal data enabled us to investigate possible causal associations between substance use behaviors and functional connectivities.
109-1	19845-19852	However	_
109-2	19853-19854	,	_
109-3	19855-19859	this	_
109-4	19860-19872	longitudinal	_
109-5	19873-19877	data	_
109-6	19878-19885	enabled	_
109-7	19886-19888	us	_
109-8	19889-19891	to	_
109-9	19892-19903	investigate	_
109-10	19904-19912	possible	_
109-11	19913-19919	causal	_
109-12	19920-19932	associations	_
109-13	19933-19940	between	_
109-14	19941-19950	substance	_
109-15	19951-19954	use	_
109-16	19955-19964	behaviors	_
109-17	19965-19968	and	_
109-18	19969-19979	functional	_
109-19	19980-19994	connectivities	_
109-20	19995-19996	.	_

Text=Therefore, for the dataset at age 14, to investigate possible causal associations between drinking and functional connectivities, we focused only on the subjects who drank two or fewer drinks per drinking day.
110-1	19997-20006	Therefore	_
110-2	20007-20008	,	_
110-3	20009-20012	for	_
110-4	20013-20016	the	_
110-5	20017-20024	dataset	_
110-6	20025-20027	at	_
110-7	20028-20031	age	_
110-8	20032-20034	14	_
110-9	20035-20036	,	_
110-10	20037-20039	to	_
110-11	20040-20051	investigate	_
110-12	20052-20060	possible	_
110-13	20061-20067	causal	_
110-14	20068-20080	associations	_
110-15	20081-20088	between	_
110-16	20089-20097	drinking	_
110-17	20098-20101	and	_
110-18	20102-20112	functional	_
110-19	20113-20127	connectivities	_
110-20	20128-20129	,	_
110-21	20130-20132	we	_
110-22	20133-20140	focused	_
110-23	20141-20145	only	_
110-24	20146-20148	on	_
110-25	20149-20152	the	_
110-26	20153-20161	subjects	_
110-27	20162-20165	who	_
110-28	20166-20171	drank	_
110-29	20172-20175	two	_
110-30	20176-20178	or	_
110-31	20179-20184	fewer	_
110-32	20185-20191	drinks	_
110-33	20192-20195	per	_
110-34	20196-20204	drinking	_
110-35	20205-20208	day	_
110-36	20209-20210	.	_

Text=(This was the great majority of participants.)
111-1	20211-20212	(	_
111-2	20213-20217	This	_
111-3	20218-20221	was	_
111-4	20222-20225	the	_
111-5	20226-20231	great	_
111-6	20232-20240	majority	_
111-7	20241-20243	of	_
111-8	20244-20256	participants	_
111-9	20257-20258	.	_
111-10	20259-20260	)	_

Text=We also divided all participants into two groups according to their drinking behavior at age 14 and 19.
112-1	20261-20263	We	_
112-2	20264-20268	also	_
112-3	20269-20276	divided	_
112-4	20277-20280	all	_
112-5	20281-20293	participants	_
112-6	20294-20298	into	_
112-7	20299-20302	two	_
112-8	20303-20309	groups	_
112-9	20310-20319	according	_
112-10	20320-20322	to	_
112-11	20323-20328	their	_
112-12	20329-20337	drinking	_
112-13	20338-20346	behavior	_
112-14	20347-20349	at	_
112-15	20350-20353	age	_
112-16	20354-20356	14	_
112-17	20357-20360	and	_
112-18	20361-20363	19	_
112-19	20364-20365	.	_

Text=Specifically, a Future Low Amount (FLA) group with 86 participants drank with two or fewer drinks per drinking day at both age 14 and 19.
113-1	20366-20378	Specifically	_
113-2	20379-20380	,	_
113-3	20381-20382	a	_
113-4	20383-20389	Future	http://maven.renci.org/NeuroBridge/neurobridge#CorrelationMeasure
113-5	20390-20393	Low	http://maven.renci.org/NeuroBridge/neurobridge#CorrelationMeasure
113-6	20394-20400	Amount	http://maven.renci.org/NeuroBridge/neurobridge#CorrelationMeasure
113-7	20401-20402	(	http://maven.renci.org/NeuroBridge/neurobridge#CorrelationMeasure
113-8	20403-20406	FLA	http://maven.renci.org/NeuroBridge/neurobridge#CorrelationMeasure
113-9	20407-20408	)	http://maven.renci.org/NeuroBridge/neurobridge#CorrelationMeasure
113-10	20409-20414	group	_
113-11	20415-20419	with	_
113-12	20420-20422	86	_
113-13	20423-20435	participants	_
113-14	20436-20441	drank	_
113-15	20442-20446	with	_
113-16	20447-20450	two	_
113-17	20451-20453	or	_
113-18	20454-20459	fewer	_
113-19	20460-20466	drinks	_
113-20	20467-20470	per	_
113-21	20471-20479	drinking	_
113-22	20480-20483	day	_
113-23	20484-20486	at	_
113-24	20487-20491	both	_
113-25	20492-20495	age	_
113-26	20496-20498	14	_
113-27	20499-20502	and	_
113-28	20503-20505	19	_
113-29	20506-20507	.	_

Text=A Future High Amount (FHA) group with 91 participants drank with three or more drinks per drinking day at age 19.
114-1	20508-20509	A	_
114-2	20510-20516	Future	http://maven.renci.org/NeuroBridge/neurobridge#HighRisk
114-3	20517-20521	High	http://maven.renci.org/NeuroBridge/neurobridge#HighRisk
114-4	20522-20528	Amount	http://maven.renci.org/NeuroBridge/neurobridge#HighRisk
114-5	20529-20530	(	http://maven.renci.org/NeuroBridge/neurobridge#HighRisk
114-6	20531-20534	FHA	http://maven.renci.org/NeuroBridge/neurobridge#HighRisk
114-7	20535-20536	)	http://maven.renci.org/NeuroBridge/neurobridge#HighRisk
114-8	20537-20542	group	_
114-9	20543-20547	with	_
114-10	20548-20550	91	_
114-11	20551-20563	participants	_
114-12	20564-20569	drank	_
114-13	20570-20574	with	_
114-14	20575-20580	three	_
114-15	20581-20583	or	_
114-16	20584-20588	more	_
114-17	20589-20595	drinks	_
114-18	20596-20599	per	_
114-19	20600-20608	drinking	_
114-20	20609-20612	day	_
114-21	20613-20615	at	_
114-22	20616-20619	age	_
114-23	20620-20622	19	_
114-24	20623-20624	.	_

Text=It should be noted that both of these groups drank two or fewer drinks per drinking day at age 14.
115-1	20625-20627	It	_
115-2	20628-20634	should	_
115-3	20635-20637	be	_
115-4	20638-20643	noted	_
115-5	20644-20648	that	_
115-6	20649-20653	both	_
115-7	20654-20656	of	_
115-8	20657-20662	these	_
115-9	20663-20669	groups	_
115-10	20670-20675	drank	_
115-11	20676-20679	two	_
115-12	20680-20682	or	_
115-13	20683-20688	fewer	_
115-14	20689-20695	drinks	_
115-15	20696-20699	per	_
115-16	20700-20708	drinking	_
115-17	20709-20712	day	_
115-18	20713-20715	at	_
115-19	20716-20719	age	_
115-20	20720-20722	14	_
115-21	20723-20724	.	_

Text=Similarly to the above, for the analysis of smoking, we still focused on the participants who never smoked cigarettes at age 14: specifically, on a future non-smoking group with 56 participants who never smoked at both age 14 and 19; and a future regular smoking group with 19 participants who experienced smoking at age 19.
116-1	20725-20734	Similarly	_
116-2	20735-20737	to	_
116-3	20738-20741	the	_
116-4	20742-20747	above	_
116-5	20748-20749	,	_
116-6	20750-20753	for	_
116-7	20754-20757	the	_
116-8	20758-20766	analysis	_
116-9	20767-20769	of	_
116-10	20770-20777	smoking	_
116-11	20778-20779	,	_
116-12	20780-20782	we	_
116-13	20783-20788	still	_
116-14	20789-20796	focused	_
116-15	20797-20799	on	_
116-16	20800-20803	the	_
116-17	20804-20816	participants	_
116-18	20817-20820	who	_
116-19	20821-20826	never	_
116-20	20827-20833	smoked	_
116-21	20834-20844	cigarettes	_
116-22	20845-20847	at	_
116-23	20848-20851	age	_
116-24	20852-20854	14	_
116-25	20855-20856	:	_
116-26	20857-20869	specifically	_
116-27	20870-20871	,	_
116-28	20872-20874	on	_
116-29	20875-20876	a	_
116-30	20877-20883	future	_
116-31	20884-20895	non-smoking	_
116-32	20896-20901	group	_
116-33	20902-20906	with	_
116-34	20907-20909	56	_
116-35	20910-20922	participants	_
116-36	20923-20926	who	_
116-37	20927-20932	never	_
116-38	20933-20939	smoked	_
116-39	20940-20942	at	_
116-40	20943-20947	both	_
116-41	20948-20951	age	_
116-42	20952-20954	14	_
116-43	20955-20958	and	_
116-44	20959-20961	19	_
116-45	20962-20963	;	_
116-46	20964-20967	and	_
116-47	20968-20969	a	_
116-48	20970-20976	future	_
116-49	20977-20984	regular	_
116-50	20985-20992	smoking	_
116-51	20993-20998	group	_
116-52	20999-21003	with	_
116-53	21004-21006	19	_
116-54	21007-21019	participants	_
116-55	21020-21023	who	_
116-56	21024-21035	experienced	_
116-57	21036-21043	smoking	_
116-58	21044-21046	at	_
116-59	21047-21050	age	_
116-60	21051-21053	19	_
116-61	21054-21055	.	_

Text=Then a two sample two-tailed t-test was used to assess the difference between the (F) LA group and (F) HA group and the smoking and non-smoking groups in the datasets at both the ages of 14 and 19 after removing the effect of gender, BMI, head motion (mean FD) and the use of the another substances use.
117-1	21056-21060	Then	_
117-2	21061-21062	a	_
117-3	21063-21066	two	_
117-4	21067-21073	sample	_
117-5	21074-21084	two-tailed	_
117-6	21085-21091	t-test	_
117-7	21092-21095	was	_
117-8	21096-21100	used	_
117-9	21101-21103	to	_
117-10	21104-21110	assess	_
117-11	21111-21114	the	_
117-12	21115-21125	difference	_
117-13	21126-21133	between	_
117-14	21134-21137	the	_
117-15	21138-21139	(	_
117-16	21140-21141	F	_
117-17	21142-21143	)	_
117-18	21144-21146	LA	_
117-19	21147-21152	group	_
117-20	21153-21156	and	_
117-21	21157-21158	(	_
117-22	21159-21160	F	_
117-23	21161-21162	)	_
117-24	21163-21165	HA	_
117-25	21166-21171	group	_
117-26	21172-21175	and	_
117-27	21176-21179	the	_
117-28	21180-21187	smoking	_
117-29	21188-21191	and	_
117-30	21192-21203	non-smoking	_
117-31	21204-21210	groups	_
117-32	21211-21213	in	_
117-33	21214-21217	the	_
117-34	21218-21226	datasets	_
117-35	21227-21229	at	_
117-36	21230-21234	both	_
117-37	21235-21238	the	_
117-38	21239-21243	ages	_
117-39	21244-21246	of	_
117-40	21247-21249	14	_
117-41	21250-21253	and	_
117-42	21254-21256	19	_
117-43	21257-21262	after	_
117-44	21263-21271	removing	_
117-45	21272-21275	the	_
117-46	21276-21282	effect	_
117-47	21283-21285	of	_
117-48	21286-21292	gender	_
117-49	21293-21294	,	_
117-50	21295-21298	BMI	_
117-51	21299-21300	,	_
117-52	21301-21305	head	_
117-53	21306-21312	motion	_
117-54	21313-21314	(	_
117-55	21315-21319	mean	_
117-56	21320-21322	FD	_
117-57	21323-21324	)	_
117-58	21325-21328	and	_
117-59	21329-21332	the	_
117-60	21333-21336	use	_
117-61	21337-21339	of	_
117-62	21340-21343	the	_
117-63	21344-21351	another	_
117-64	21352-21362	substances	_
117-65	21363-21366	use	_
117-66	21367-21368	.	_

Text=We also investigate the impulsivity of participants at age 14 by using the IMAGEN dataset.
118-1	21369-21371	We	_
118-2	21372-21376	also	_
118-3	21377-21388	investigate	_
118-4	21389-21392	the	_
118-5	21393-21404	impulsivity	_
118-6	21405-21407	of	_
118-7	21408-21420	participants	_
118-8	21421-21423	at	_
118-9	21424-21427	age	_
118-10	21428-21430	14	_
118-11	21431-21433	by	_
118-12	21434-21439	using	_
118-13	21440-21443	the	_
118-14	21444-21450	IMAGEN	_
118-15	21451-21458	dataset	_
118-16	21459-21460	.	_

Text=The impulsivity measure is based on the Substance Use Risk Profile Scale by using the sum of the following question scores: I often don't think things through before I speak.
119-1	21461-21464	The	_
119-2	21465-21476	impulsivity	_
119-3	21477-21484	measure	_
119-4	21485-21487	is	_
119-5	21488-21493	based	_
119-6	21494-21496	on	_
119-7	21497-21500	the	_
119-8	21501-21510	Substance	http://maven.renci.org/NeuroBridge/neurobridge#SubstanceUseScale
119-9	21511-21514	Use	http://maven.renci.org/NeuroBridge/neurobridge#SubstanceUseScale
119-10	21515-21519	Risk	http://maven.renci.org/NeuroBridge/neurobridge#SubstanceUseScale
119-11	21520-21527	Profile	http://maven.renci.org/NeuroBridge/neurobridge#SubstanceUseScale
119-12	21528-21533	Scale	http://maven.renci.org/NeuroBridge/neurobridge#SubstanceUseScale
119-13	21534-21536	by	_
119-14	21537-21542	using	_
119-15	21543-21546	the	_
119-16	21547-21550	sum	_
119-17	21551-21553	of	_
119-18	21554-21557	the	_
119-19	21558-21567	following	_
119-20	21568-21576	question	_
119-21	21577-21583	scores	_
119-22	21584-21585	:	_
119-23	21586-21587	I	_
119-24	21588-21593	often	_
119-25	21594-21596	do	_
119-26	21597-21600	n't	_
119-27	21601-21606	think	_
119-28	21607-21613	things	_
119-29	21614-21621	through	_
119-30	21622-21628	before	_
119-31	21629-21630	I	_
119-32	21631-21636	speak	_
119-33	21637-21638	.	_

Text=I often involve myself in situations that I later regret being involved in.
120-1	21639-21640	I	_
120-2	21641-21646	often	_
120-3	21647-21654	involve	_
120-4	21655-21661	myself	_
120-5	21662-21664	in	_
120-6	21665-21675	situations	_
120-7	21676-21680	that	_
120-8	21681-21682	I	_
120-9	21683-21688	later	_
120-10	21689-21695	regret	_
120-11	21696-21701	being	_
120-12	21702-21710	involved	_
120-13	21711-21713	in	_
120-14	21714-21715	.	_

Text=I usually act without stopping to think.
121-1	21716-21717	I	_
121-2	21718-21725	usually	_
121-3	21726-21729	act	_
121-4	21730-21737	without	_
121-5	21738-21746	stopping	_
121-6	21747-21749	to	_
121-7	21750-21755	think	_
121-8	21756-21757	.	_

Text=Generally, I am an impulsive person.
122-1	21758-21767	Generally	_
122-2	21768-21769	,	_
122-3	21770-21771	I	_
122-4	21772-21774	am	_
122-5	21775-21777	an	_
122-6	21778-21787	impulsive	_
122-7	21788-21794	person	_
122-8	21795-21796	.	_

Text=I feel I have to be manipulative to get what I want.
123-1	21797-21798	I	_
123-2	21799-21803	feel	_
123-3	21804-21805	I	_
123-4	21806-21810	have	_
123-5	21811-21813	to	_
123-6	21814-21816	be	_
123-7	21817-21829	manipulative	_
123-8	21830-21832	to	_
123-9	21833-21836	get	_
123-10	21837-21841	what	_
123-11	21842-21843	I	_
123-12	21844-21848	want	_
123-13	21849-21850	.	_

Text=Drinking and smoking behavior We used the European School Survey Project on Alcohol and Other Drugs (ESPAD) at ages 14 and 19 years to assess life time drinking and smoking.
124-1	21851-21859	Drinking	_
124-2	21860-21863	and	_
124-3	21864-21871	smoking	_
124-4	21872-21880	behavior	_
124-5	21881-21883	We	_
124-6	21884-21888	used	_
124-7	21889-21892	the	_
124-8	21893-21901	European	_
124-9	21902-21908	School	_
124-10	21909-21915	Survey	_
124-11	21916-21923	Project	_
124-12	21924-21926	on	_
124-13	21927-21934	Alcohol	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse
124-14	21935-21938	and	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse
124-15	21939-21944	Other	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse
124-16	21945-21950	Drugs	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse
124-17	21951-21952	(	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse
124-18	21953-21958	ESPAD	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse
124-19	21959-21960	)	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse
124-20	21961-21963	at	_
124-21	21964-21968	ages	_
124-22	21969-21971	14	_
124-23	21972-21975	and	_
124-24	21976-21978	19	_
124-25	21979-21984	years	_
124-26	21985-21987	to	_
124-27	21988-21994	assess	_
124-28	21995-21999	life	_
124-29	22000-22004	time	_
124-30	22005-22013	drinking	_
124-31	22014-22017	and	_
124-32	22018-22025	smoking	_
124-33	22026-22027	.	_

Text=The primary question of interest was regarding lifetime alcohol and cigarette use and the questionnaire were as follows: 1.
125-1	22028-22031	The	_
125-2	22032-22039	primary	_
125-3	22040-22048	question	_
125-4	22049-22051	of	_
125-5	22052-22060	interest	_
125-6	22061-22064	was	_
125-7	22065-22074	regarding	_
125-8	22075-22083	lifetime	_
125-9	22084-22091	alcohol	_
125-10	22092-22095	and	_
125-11	22096-22105	cigarette	_
125-12	22106-22109	use	_
125-13	22110-22113	and	_
125-14	22114-22117	the	_
125-15	22118-22131	questionnaire	_
125-16	22132-22136	were	_
125-17	22137-22139	as	_
125-18	22140-22147	follows	_
125-19	22148-22149	:	_
125-20	22150-22151	1	_
125-21	22152-22153	.	_

Text=On how many occasions during your lifetime have you smoked cigarettes?
126-1	22154-22156	On	_
126-2	22157-22160	how	_
126-3	22161-22165	many	_
126-4	22166-22175	occasions	_
126-5	22176-22182	during	_
126-6	22183-22187	your	_
126-7	22188-22196	lifetime	_
126-8	22197-22201	have	_
126-9	22202-22205	you	_
126-10	22206-22212	smoked	_
126-11	22213-22223	cigarettes	_
126-12	22224-22225	?	_

Text=0: 0 1: 1–2 2: 3–5 3: 6–9 4: 10–19 5: 20–39 6: 40 or mor 2.
127-1	22226-22227	0	_
127-2	22228-22229	:	_
127-3	22230-22231	0	_
127-4	22232-22233	1	_
127-5	22234-22235	:	_
127-6	22236-22239	1–2	_
127-7	22240-22241	2	_
127-8	22242-22243	:	_
127-9	22244-22247	3–5	_
127-10	22248-22249	3	_
127-11	22250-22251	:	_
127-12	22252-22255	6–9	_
127-13	22256-22257	4	_
127-14	22258-22259	:	_
127-15	22260-22265	10–19	_
127-16	22266-22267	5	_
127-17	22268-22269	:	_
127-18	22270-22275	20–39	_
127-19	22276-22277	6	_
127-20	22278-22279	:	_
127-21	22280-22282	40	_
127-22	22283-22285	or	_
127-23	22286-22289	mor	_
127-24	22290-22291	2	_
127-25	22292-22293	.	_

Text=How frequently have you smoked cigarettes during the last 30 days?
128-1	22294-22297	How	_
128-2	22298-22308	frequently	_
128-3	22309-22313	have	_
128-4	22314-22317	you	_
128-5	22318-22324	smoked	_
128-6	22325-22335	cigarettes	_
128-7	22336-22342	during	_
128-8	22343-22346	the	_
128-9	22347-22351	last	_
128-10	22352-22354	30	_
128-11	22355-22359	days	_
128-12	22360-22361	?	_

Text=6: more than 20 cigarettes per day 999: non smoker 0: not at all 1: less than one cigarette per week 2: less than one cigarette per day 3: 1–5 cigarettes per day 4: 6–10 cigarettes per day 5: 11–20 cigarettes per day 3.
129-1	22362-22363	6	_
129-2	22364-22365	:	_
129-3	22366-22370	more	_
129-4	22371-22375	than	_
129-5	22376-22378	20	_
129-6	22379-22389	cigarettes	_
129-7	22390-22393	per	_
129-8	22394-22397	day	_
129-9	22398-22401	999	_
129-10	22402-22403	:	_
129-11	22404-22407	non	_
129-12	22408-22414	smoker	_
129-13	22415-22416	0	_
129-14	22417-22418	:	_
129-15	22419-22422	not	_
129-16	22423-22425	at	_
129-17	22426-22429	all	_
129-18	22430-22431	1	_
129-19	22432-22433	:	_
129-20	22434-22438	less	_
129-21	22439-22443	than	_
129-22	22444-22447	one	_
129-23	22448-22457	cigarette	_
129-24	22458-22461	per	_
129-25	22462-22466	week	_
129-26	22467-22468	2	_
129-27	22469-22470	:	_
129-28	22471-22475	less	_
129-29	22476-22480	than	_
129-30	22481-22484	one	_
129-31	22485-22494	cigarette	_
129-32	22495-22498	per	_
129-33	22499-22502	day	_
129-34	22503-22504	3	_
129-35	22505-22506	:	_
129-36	22507-22510	1–5	_
129-37	22511-22521	cigarettes	_
129-38	22522-22525	per	_
129-39	22526-22529	day	_
129-40	22530-22531	4	_
129-41	22532-22533	:	_
129-42	22534-22538	6–10	_
129-43	22539-22549	cigarettes	_
129-44	22550-22553	per	_
129-45	22554-22557	day	_
129-46	22558-22559	5	_
129-47	22560-22561	:	_
129-48	22562-22567	11–20	_
129-49	22568-22578	cigarettes	_
129-50	22579-22582	per	_
129-51	22583-22586	day	_
129-52	22587-22588	3	_
129-53	22589-22590	.	_

Text=How many drinks containing alcohol do you have on a typical day when you are drinking?
130-1	22591-22594	How	_
130-2	22595-22599	many	_
130-3	22600-22606	drinks	_
130-4	22607-22617	containing	_
130-5	22618-22625	alcohol	_
130-6	22626-22628	do	_
130-7	22629-22632	you	_
130-8	22633-22637	have	_
130-9	22638-22640	on	_
130-10	22641-22642	a	_
130-11	22643-22650	typical	_
130-12	22651-22654	day	_
130-13	22655-22659	when	_
130-14	22660-22663	you	_
130-15	22664-22667	are	_
130-16	22668-22676	drinking	_
130-17	22677-22678	?	_

Text=1: 1 or 2 2: 3 or 4 3: 5 or 6 4: 7 to 9 5: 10 or more 4.
131-1	22679-22680	1	_
131-2	22681-22682	:	_
131-3	22683-22684	1	_
131-4	22685-22687	or	_
131-5	22688-22689	2	_
131-6	22690-22691	2	_
131-7	22692-22693	:	_
131-8	22694-22695	3	_
131-9	22696-22698	or	_
131-10	22699-22700	4	_
131-11	22701-22702	3	_
131-12	22703-22704	:	_
131-13	22705-22706	5	_
131-14	22707-22709	or	_
131-15	22710-22711	6	_
131-16	22712-22713	4	_
131-17	22714-22715	:	_
131-18	22716-22717	7	_
131-19	22718-22720	to	_
131-20	22721-22722	9	_
131-21	22723-22724	5	_
131-22	22725-22726	:	_
131-23	22727-22729	10	_
131-24	22730-22732	or	_
131-25	22733-22737	more	_
131-26	22738-22739	4	_
131-27	22740-22741	.	_

Text=On how many occasions over the last 12 months have you had any alcoholic beverage to drink?
132-1	22742-22744	On	_
132-2	22745-22748	how	_
132-3	22749-22753	many	_
132-4	22754-22763	occasions	_
132-5	22764-22768	over	_
132-6	22769-22772	the	_
132-7	22773-22777	last	_
132-8	22778-22780	12	_
132-9	22781-22787	months	_
132-10	22788-22792	have	_
132-11	22793-22796	you	_
132-12	22797-22800	had	_
132-13	22801-22804	any	_
132-14	22805-22814	alcoholic	_
132-15	22815-22823	beverage	_
132-16	22824-22826	to	_
132-17	22827-22832	drink	_
132-18	22833-22834	?	_

Text=0: 0 1: 1–2 2: 3–5 3: 6–9 4: 10–19 5: 20–39 6: 40 or more Imaging data preprocessing for the IMAGEN dataset Data preprocessing was performed using DPARSF (http: // restfmri.net) which is a toolbox based on the SPM8 software package.
133-1	22835-22836	0	_
133-2	22837-22838	:	_
133-3	22839-22840	0	_
133-4	22841-22842	1	_
133-5	22843-22844	:	_
133-6	22845-22848	1–2	_
133-7	22849-22850	2	_
133-8	22851-22852	:	_
133-9	22853-22856	3–5	_
133-10	22857-22858	3	_
133-11	22859-22860	:	_
133-12	22861-22864	6–9	_
133-13	22865-22866	4	_
133-14	22867-22868	:	_
133-15	22869-22874	10–19	_
133-16	22875-22876	5	_
133-17	22877-22878	:	_
133-18	22879-22884	20–39	_
133-19	22885-22886	6	_
133-20	22887-22888	:	_
133-21	22889-22891	40	_
133-22	22892-22894	or	_
133-23	22895-22899	more	_
133-24	22900-22907	Imaging	_
133-25	22908-22912	data	_
133-26	22913-22926	preprocessing	_
133-27	22927-22930	for	_
133-28	22931-22934	the	_
133-29	22935-22941	IMAGEN	_
133-30	22942-22949	dataset	_
133-31	22950-22954	Data	_
133-32	22955-22968	preprocessing	_
133-33	22969-22972	was	_
133-34	22973-22982	performed	_
133-35	22983-22988	using	_
133-36	22989-22995	DPARSF	_
133-37	22996-22997	(	_
133-38	22998-23002	http	_
133-39	23003-23004	:	_
133-40	23005-23007	//	_
133-41	23008-23020	restfmri.net	_
133-42	23021-23022	)	_
133-43	23023-23028	which	_
133-44	23029-23031	is	_
133-45	23032-23033	a	_
133-46	23034-23041	toolbox	_
133-47	23042-23047	based	_
133-48	23048-23050	on	_
133-49	23051-23054	the	_
133-50	23055-23059	SPM8	_
133-51	23060-23068	software	_
133-52	23069-23076	package	_
133-53	23077-23078	.	_

Text=The first 10 EPI scans were discarded to suppress equilibration effects.
134-1	23079-23082	The	_
134-2	23083-23088	first	_
134-3	23089-23091	10	_
134-4	23092-23095	EPI	_
134-5	23096-23101	scans	_
134-6	23102-23106	were	_
134-7	23107-23116	discarded	_
134-8	23117-23119	to	_
134-9	23120-23128	suppress	_
134-10	23129-23142	equilibration	_
134-11	23143-23150	effects	_
134-12	23151-23152	.	_

Text=The remaining scans of each subject underwent slice timing correction by sinc interpolating volume slices, motion correction for volume to volume displacement, spatial normalization to standard Montreal Neurological Institute (MNI) space using affine transformation and nonlinear deformation with a voxel size of, followed by spatial smoothing (6 mm Full Width Half Maximum FWHM).
135-1	23153-23156	The	_
135-2	23157-23166	remaining	_
135-3	23167-23172	scans	_
135-4	23173-23175	of	_
135-5	23176-23180	each	_
135-6	23181-23188	subject	_
135-7	23189-23198	underwent	_
135-8	23199-23204	slice	_
135-9	23205-23211	timing	_
135-10	23212-23222	correction	_
135-11	23223-23225	by	_
135-12	23226-23230	sinc	_
135-13	23231-23244	interpolating	_
135-14	23245-23251	volume	_
135-15	23252-23258	slices	_
135-16	23259-23260	,	_
135-17	23261-23267	motion	_
135-18	23268-23278	correction	_
135-19	23279-23282	for	_
135-20	23283-23289	volume	_
135-21	23290-23292	to	_
135-22	23293-23299	volume	_
135-23	23300-23312	displacement	_
135-24	23313-23314	,	_
135-25	23315-23322	spatial	_
135-26	23323-23336	normalization	_
135-27	23337-23339	to	_
135-28	23340-23348	standard	_
135-29	23349-23357	Montreal	_
135-30	23358-23370	Neurological	_
135-31	23371-23380	Institute	_
135-32	23381-23382	(	_
135-33	23383-23386	MNI	_
135-34	23387-23388	)	_
135-35	23389-23394	space	_
135-36	23395-23400	using	_
135-37	23401-23407	affine	_
135-38	23408-23422	transformation	_
135-39	23423-23426	and	_
135-40	23427-23436	nonlinear	_
135-41	23437-23448	deformation	_
135-42	23449-23453	with	_
135-43	23454-23455	a	_
135-44	23456-23461	voxel	_
135-45	23462-23466	size	_
135-46	23467-23469	of	_
135-47	23470-23471	,	_
135-48	23472-23480	followed	_
135-49	23481-23483	by	_
135-50	23484-23491	spatial	_
135-51	23492-23501	smoothing	_
135-52	23502-23503	(	_
135-53	23504-23505	6	_
135-54	23506-23508	mm	_
135-55	23509-23513	Full	_
135-56	23514-23519	Width	_
135-57	23520-23524	Half	_
135-58	23525-23532	Maximum	_
135-59	23533-23537	FWHM	_
135-60	23538-23539	)	_
135-61	23540-23541	.	_

Text=To remove the sources of spurious correlations present in resting-state BOLD data, all fMRI time-series underwent band-pass temporal filtering (0.01-0.1 Hz), nuisance signal removal from the ventricles, and deep white matter, and regressing out any effects of head motion using Friston ’ s 24 head motion parameters procedure.
136-1	23542-23544	To	_
136-2	23545-23551	remove	_
136-3	23552-23555	the	_
136-4	23556-23563	sources	_
136-5	23564-23566	of	_
136-6	23567-23575	spurious	_
136-7	23576-23588	correlations	_
136-8	23589-23596	present	_
136-9	23597-23599	in	_
136-10	23600-23613	resting-state	_
136-11	23614-23618	BOLD	_
136-12	23619-23623	data	_
136-13	23624-23625	,	_
136-14	23626-23629	all	_
136-15	23630-23634	fMRI	_
136-16	23635-23646	time-series	_
136-17	23647-23656	underwent	_
136-18	23657-23666	band-pass	_
136-19	23667-23675	temporal	_
136-20	23676-23685	filtering	_
136-21	23686-23687	(	_
136-22	23688-23696	0.01-0.1	_
136-23	23697-23699	Hz	_
136-24	23700-23701	)	_
136-25	23702-23703	,	_
136-26	23704-23712	nuisance	_
136-27	23713-23719	signal	_
136-28	23720-23727	removal	_
136-29	23728-23732	from	_
136-30	23733-23736	the	_
136-31	23737-23747	ventricles	_
136-32	23748-23749	,	_
136-33	23750-23753	and	_
136-34	23754-23758	deep	_
136-35	23759-23764	white	_
136-36	23765-23771	matter	_
136-37	23772-23773	,	_
136-38	23774-23777	and	_
136-39	23778-23788	regressing	_
136-40	23789-23792	out	_
136-41	23793-23796	any	_
136-42	23797-23804	effects	_
136-43	23805-23807	of	_
136-44	23808-23812	head	_
136-45	23813-23819	motion	_
136-46	23820-23825	using	_
136-47	23826-23833	Friston	_
136-48	23834-23835	’	_
136-49	23836-23837	s	_
136-50	23838-23840	24	_
136-51	23841-23845	head	_
136-52	23846-23852	motion	_
136-53	23853-23863	parameters	_
136-54	23864-23873	procedure	_
136-55	23874-23875	.	_

Text=Finally, subjects with the mean framewise displacement (FD) of head motion large than 0.3 were completely excluded from the analysis as it is likely that such high-level of movement would have had an influence on several volumes.
137-1	23876-23883	Finally	_
137-2	23884-23885	,	_
137-3	23886-23894	subjects	_
137-4	23895-23899	with	_
137-5	23900-23903	the	_
137-6	23904-23908	mean	_
137-7	23909-23918	framewise	_
137-8	23919-23931	displacement	_
137-9	23932-23933	(	_
137-10	23934-23936	FD	_
137-11	23937-23938	)	_
137-12	23939-23941	of	_
137-13	23942-23946	head	_
137-14	23947-23953	motion	_
137-15	23954-23959	large	_
137-16	23960-23964	than	_
137-17	23965-23968	0.3	_
137-18	23969-23973	were	_
137-19	23974-23984	completely	_
137-20	23985-23993	excluded	_
137-21	23994-23998	from	_
137-22	23999-24002	the	_
137-23	24003-24011	analysis	_
137-24	24012-24014	as	_
137-25	24015-24017	it	_
137-26	24018-24020	is	_
137-27	24021-24027	likely	_
137-28	24028-24032	that	_
137-29	24033-24037	such	_
137-30	24038-24048	high-level	_
137-31	24049-24051	of	_
137-32	24052-24060	movement	_
137-33	24061-24066	would	_
137-34	24067-24071	have	_
137-35	24072-24075	had	_
137-36	24076-24078	an	_
137-37	24079-24088	influence	_
137-38	24089-24091	on	_
137-39	24092-24099	several	_
137-40	24100-24107	volumes	_
137-41	24108-24109	.	_

Text=Methodological notes Effect of the pipeline of data preprocessing A comparison between different pipelines of data preprocessing was performed, as follows.
138-1	24110-24124	Methodological	_
138-2	24125-24130	notes	_
138-3	24131-24137	Effect	_
138-4	24138-24140	of	_
138-5	24141-24144	the	_
138-6	24145-24153	pipeline	_
138-7	24154-24156	of	_
138-8	24157-24161	data	_
138-9	24162-24175	preprocessing	_
138-10	24176-24177	A	_
138-11	24178-24188	comparison	_
138-12	24189-24196	between	_
138-13	24197-24206	different	_
138-14	24207-24216	pipelines	_
138-15	24217-24219	of	_
138-16	24220-24224	data	_
138-17	24225-24238	preprocessing	_
138-18	24239-24242	was	_
138-19	24243-24252	performed	_
138-20	24253-24254	,	_
138-21	24255-24257	as	_
138-22	24258-24265	follows	_
138-23	24266-24267	.	_

Text=1) The complete HCP pipeline.
139-1	24268-24269	1	_
139-2	24270-24271	)	_
139-3	24272-24275	The	_
139-4	24276-24284	complete	_
139-5	24285-24288	HCP	_
139-6	24289-24297	pipeline	_
139-7	24298-24299	.	_

Text=Data pre-processing was carried out using FSL (FMRIB Software Library), FreeSurfer, and the Connectome Workbench software.
140-1	24300-24304	Data	_
140-2	24305-24319	pre-processing	_
140-3	24320-24323	was	_
140-4	24324-24331	carried	_
140-5	24332-24335	out	_
140-6	24336-24341	using	_
140-7	24342-24345	FSL	_
140-8	24346-24347	(	_
140-9	24348-24353	FMRIB	_
140-10	24354-24362	Software	_
140-11	24363-24370	Library	_
140-12	24371-24372	)	_
140-13	24373-24374	,	_
140-14	24375-24385	FreeSurfer	_
140-15	24386-24387	,	_
140-16	24388-24391	and	_
140-17	24392-24395	the	_
140-18	24396-24406	Connectome	_
140-19	24407-24416	Workbench	_
140-20	24417-24425	software	_
140-21	24426-24427	.	_

Text=All the data preprocessing procedures were performed by the human connectome project (HCP) as described in.
141-1	24428-24431	All	_
141-2	24432-24435	the	_
141-3	24436-24440	data	_
141-4	24441-24454	preprocessing	_
141-5	24455-24465	procedures	_
141-6	24466-24470	were	_
141-7	24471-24480	performed	_
141-8	24481-24483	by	_
141-9	24484-24487	the	_
141-10	24488-24493	human	_
141-11	24494-24504	connectome	_
141-12	24505-24512	project	_
141-13	24513-24514	(	_
141-14	24515-24518	HCP	_
141-15	24519-24520	)	_
141-16	24521-24523	as	_
141-17	24524-24533	described	_
141-18	24534-24536	in	_
141-19	24537-24538	.	_

Text=Briefly, the data preprocessing included correction for spatial and gradient distortions and head motion, intensity normalization and bias field removal, registration to the T1 weighted structural image, transformation to 2 mm Montreal Neurological Institute (MNI) space, and the FIX artefact removal procedure.
142-1	24539-24546	Briefly	_
142-2	24547-24548	,	_
142-3	24549-24552	the	_
142-4	24553-24557	data	_
142-5	24558-24571	preprocessing	_
142-6	24572-24580	included	_
142-7	24581-24591	correction	_
142-8	24592-24595	for	_
142-9	24596-24603	spatial	_
142-10	24604-24607	and	_
142-11	24608-24616	gradient	_
142-12	24617-24628	distortions	_
142-13	24629-24632	and	_
142-14	24633-24637	head	_
142-15	24638-24644	motion	_
142-16	24645-24646	,	_
142-17	24647-24656	intensity	_
142-18	24657-24670	normalization	_
142-19	24671-24674	and	_
142-20	24675-24679	bias	_
142-21	24680-24685	field	_
142-22	24686-24693	removal	_
142-23	24694-24695	,	_
142-24	24696-24708	registration	_
142-25	24709-24711	to	_
142-26	24712-24715	the	_
142-27	24716-24718	T1	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
142-28	24719-24727	weighted	_
142-29	24728-24738	structural	_
142-30	24739-24744	image	_
142-31	24745-24746	,	_
142-32	24747-24761	transformation	_
142-33	24762-24764	to	_
142-34	24765-24766	2	_
142-35	24767-24769	mm	_
142-36	24770-24778	Montreal	_
142-37	24779-24791	Neurological	_
142-38	24792-24801	Institute	_
142-39	24802-24803	(	_
142-40	24804-24807	MNI	_
142-41	24808-24809	)	_
142-42	24810-24815	space	_
142-43	24816-24817	,	_
142-44	24818-24821	and	_
142-45	24822-24825	the	_
142-46	24826-24829	FIX	_
142-47	24830-24838	artefact	_
142-48	24839-24846	removal	_
142-49	24847-24856	procedure	_
142-50	24857-24858	.	_

Text=2) The HCP minimal preprocessing pipeline + other standard preprocessing procedures but without global signal removal.
143-1	24859-24860	2	_
143-2	24861-24862	)	_
143-3	24863-24866	The	_
143-4	24867-24870	HCP	_
143-5	24871-24878	minimal	_
143-6	24879-24892	preprocessing	_
143-7	24893-24901	pipeline	_
143-8	24902-24903	+	_
143-9	24904-24909	other	_
143-10	24910-24918	standard	_
143-11	24919-24932	preprocessing	_
143-12	24933-24943	procedures	_
143-13	24944-24947	but	_
143-14	24948-24955	without	_
143-15	24956-24962	global	_
143-16	24963-24969	signal	_
143-17	24970-24977	removal	_
143-18	24978-24979	.	_

Text=The HCP minimal preprocessing pipeline was used for the HCP data set.
144-1	24980-24983	The	_
144-2	24984-24987	HCP	_
144-3	24988-24995	minimal	_
144-4	24996-25009	preprocessing	_
144-5	25010-25018	pipeline	_
144-6	25019-25022	was	_
144-7	25023-25027	used	_
144-8	25028-25031	for	_
144-9	25032-25035	the	_
144-10	25036-25039	HCP	_
144-11	25040-25044	data	_
144-12	25045-25048	set	_
144-13	25049-25050	.	_

Text=This pipeline includes artifact removal, motion correction and registration to standard space.
145-1	25051-25055	This	_
145-2	25056-25064	pipeline	_
145-3	25065-25073	includes	_
145-4	25074-25082	artifact	_
145-5	25083-25090	removal	_
145-6	25091-25092	,	_
145-7	25093-25099	motion	_
145-8	25100-25110	correction	_
145-9	25111-25114	and	_
145-10	25115-25127	registration	_
145-11	25128-25130	to	_
145-12	25131-25139	standard	_
145-13	25140-25145	space	_
145-14	25146-25147	.	_

Text=Then standard preprocessing procedures were applied to the fMRI data: first the linear trend and quadratic term were removed from these functional images; several nuisance signals were regressed from the time course of each voxel using multiple linear regression, including cerebrospinal fluid, white matter and head motion parameters; finally, temporal band-pass filtering (0.09–0.1 Hz) was performed to reduce the influence of low-frequency drift and the high-frequency physiological noise.
146-1	25148-25152	Then	_
146-2	25153-25161	standard	_
146-3	25162-25175	preprocessing	_
146-4	25176-25186	procedures	_
146-5	25187-25191	were	_
146-6	25192-25199	applied	_
146-7	25200-25202	to	_
146-8	25203-25206	the	_
146-9	25207-25211	fMRI	_
146-10	25212-25216	data	_
146-11	25217-25218	:	_
146-12	25219-25224	first	_
146-13	25225-25228	the	_
146-14	25229-25235	linear	_
146-15	25236-25241	trend	_
146-16	25242-25245	and	_
146-17	25246-25255	quadratic	_
146-18	25256-25260	term	_
146-19	25261-25265	were	_
146-20	25266-25273	removed	_
146-21	25274-25278	from	_
146-22	25279-25284	these	_
146-23	25285-25295	functional	_
146-24	25296-25302	images	_
146-25	25303-25304	;	_
146-26	25305-25312	several	_
146-27	25313-25321	nuisance	_
146-28	25322-25329	signals	_
146-29	25330-25334	were	_
146-30	25335-25344	regressed	_
146-31	25345-25349	from	_
146-32	25350-25353	the	_
146-33	25354-25358	time	_
146-34	25359-25365	course	_
146-35	25366-25368	of	_
146-36	25369-25373	each	_
146-37	25374-25379	voxel	_
146-38	25380-25385	using	_
146-39	25386-25394	multiple	_
146-40	25395-25401	linear	_
146-41	25402-25412	regression	_
146-42	25413-25414	,	_
146-43	25415-25424	including	_
146-44	25425-25438	cerebrospinal	_
146-45	25439-25444	fluid	_
146-46	25445-25446	,	_
146-47	25447-25452	white	_
146-48	25453-25459	matter	_
146-49	25460-25463	and	_
146-50	25464-25468	head	_
146-51	25469-25475	motion	_
146-52	25476-25486	parameters	_
146-53	25487-25488	;	_
146-54	25489-25496	finally	_
146-55	25497-25498	,	_
146-56	25499-25507	temporal	_
146-57	25508-25517	band-pass	_
146-58	25518-25527	filtering	_
146-59	25528-25529	(	_
146-60	25530-25538	0.09–0.1	_
146-61	25539-25541	Hz	_
146-62	25542-25543	)	_
146-63	25544-25547	was	_
146-64	25548-25557	performed	_
146-65	25558-25560	to	_
146-66	25561-25567	reduce	_
146-67	25568-25571	the	_
146-68	25572-25581	influence	_
146-69	25582-25584	of	_
146-70	25585-25598	low-frequency	_
146-71	25599-25604	drift	_
146-72	25605-25608	and	_
146-73	25609-25612	the	_
146-74	25613-25627	high-frequency	_
146-75	25628-25641	physiological	_
146-76	25642-25647	noise	_
146-77	25648-25649	.	_

Text=This pipeline has been widely used in previous studies based on the HCP dataset and our paper also focuses on the results based on this pipeline.
147-1	25650-25654	This	_
147-2	25655-25663	pipeline	_
147-3	25664-25667	has	_
147-4	25668-25672	been	_
147-5	25673-25679	widely	_
147-6	25680-25684	used	_
147-7	25685-25687	in	_
147-8	25688-25696	previous	_
147-9	25697-25704	studies	_
147-10	25705-25710	based	_
147-11	25711-25713	on	_
147-12	25714-25717	the	_
147-13	25718-25721	HCP	_
147-14	25722-25729	dataset	_
147-15	25730-25733	and	_
147-16	25734-25737	our	_
147-17	25738-25743	paper	_
147-18	25744-25748	also	_
147-19	25749-25756	focuses	_
147-20	25757-25759	on	_
147-21	25760-25763	the	_
147-22	25764-25771	results	_
147-23	25772-25777	based	_
147-24	25778-25780	on	_
147-25	25781-25785	this	_
147-26	25786-25794	pipeline	_
147-27	25795-25796	.	_

Text=3) The HCP minimal preprocessing pipeline + other standard preprocessing procedures and with global signal removal.
148-1	25797-25798	3	_
148-2	25799-25800	)	_
148-3	25801-25804	The	_
148-4	25805-25808	HCP	_
148-5	25809-25816	minimal	_
148-6	25817-25830	preprocessing	_
148-7	25831-25839	pipeline	_
148-8	25840-25841	+	_
148-9	25842-25847	other	_
148-10	25848-25856	standard	_
148-11	25857-25870	preprocessing	_
148-12	25871-25881	procedures	_
148-13	25882-25885	and	_
148-14	25886-25890	with	_
148-15	25891-25897	global	_
148-16	25898-25904	signal	_
148-17	25905-25912	removal	_
148-18	25913-25914	.	_

Text=Same as pipeline two but with the global signal removal.
149-1	25915-25919	Same	_
149-2	25920-25922	as	_
149-3	25923-25931	pipeline	_
149-4	25932-25935	two	_
149-5	25936-25939	but	_
149-6	25940-25944	with	_
149-7	25945-25948	the	_
149-8	25949-25955	global	_
149-9	25956-25962	signal	_
149-10	25963-25970	removal	_
149-11	25971-25972	.	_

